Index of Molecular Images
To facilitate comparison of similar structures, the images are listed by clan and family.
Clan | MEROPS ID | Inhibitor | Comment | PDB Entry |
---|---|---|---|---|
IA | I01.001 | ovomucoid inhibitor unit 1 | 1CSO_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 1CT2_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 1CT4_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 1DS2_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 1SGD_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 1SGE_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 1SGN_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 1SGY_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 2GKT | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 2GKV_A | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 2SGD_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 2SGF_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 2SGP_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 2SGQ_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 3SGQ_I | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 1OVO_A | |
IA | I01.001 | ovomucoid inhibitor unit 1 | 3OVO_A | |
IA | I01.002 | ovomucoid inhibitor unit 2 | 1R0T_B | |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with cattle chymotrypsin A | 1CHO_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | Ser18Ile mutant; complex with streptogrisin B | 1CT0_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | Asp19Ile mutant | 1DS3 |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with chymotrypsin A | 1HJA_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | NMR structure of C state | 1M8B |
IA | I01.003 | ovomucoid inhibitor unit 3 | NMR structure of T state | 1M8C |
IA | I01.003 | ovomucoid inhibitor unit 3 | NMR structure | 1OMT |
IA | I01.003 | ovomucoid inhibitor unit 3 | NMR structure | 1OMU |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with human leukocyte elastase | 1PPF_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with subtilisin Carlsberg | 1R0R_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with streptogrisin B | 1SGP_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with streptogrisin B | 1SGQ_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with streptogrisin B | 1SGR_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | NMR structure | 1TUR |
IA | I01.003 | ovomucoid inhibitor unit 3 | NMR structure | 1TUS |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with subtilisin Carlsberg | 1YU6_C |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with trypsin | 1Z7K_B |
IA | I01.003 | ovomucoid inhibitor unit 3 | N-terminally truncated form | 2GKR_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | variants Tp18Ile, His18Ile, Phe18le, and Tyr18Ile; complex with Streptomyces griseus proteinase B | 2NU0_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | variants Tp18Ile, His18Ile, Phe18le, and Tyr18Ile; complex with Streptomyces griseus proteinase B | 2NU1_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | variants Lys18Ile and Arg18Ile; complex with Streptomyces griseus proteinase B | 2NU2_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | variants Lys18Ile and Arg18Ile; complex with Streptomyces griseus proteinase B | 2NU3_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | variants Lys18Ile and Arg18Ile; complex with Streptomyces griseus proteinase B | 2NU4_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | Glu18 variant; complex with Streptomyces griseus proteinase B at pH 10.7 | 2SGE_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | complex with streptogrisin B | 3SGB_I |
IA | I01.003 | ovomucoid inhibitor unit 3 | 1OVO | |
IA | I01.003 | ovomucoid inhibitor unit 3 | 2OVO | |
IA | I01.003 | ovomucoid inhibitor unit 3 | cleaved form | 3OVO |
IA | I01.003 | ovomucoid inhibitor unit 3 | 4OVO | |
IA | I01.011 | SPINK1 | variant 3; complex with cattle chymotrypsin A | 1CGI_I |
IA | I01.011 | SPINK1 | variant 4; complex with cattle chymotrypsin A | 1CGJ_I |
IA | I01.011 | SPINK1 | variant 3 | 1HPT |
IA | I01.011 | SPINK1 | complex with pig cationic trypsin | 1TGS_I |
IA | I01.012 | SPINK2 | 2JXD | |
IA | I01.013 | SPINK5 inhibitor unit 1 | NMR structure | 1HDL |
IA | I01.015 | SPINK6 | NMR structure | 1BUS |
IA | I01.015 | SPINK6 | NMR structure | 2BUS |
IA | I01.018 | elastase inhibitor (Anemonia sulcata) | NMR structure | 1Y1B |
IA | I01.018 | elastase inhibitor (Anemonia sulcata) | NMR structure; Cys4Ala, Leu6Cyes, Gly31Cys, Cys34Ala mutant | 1Y1C |
IA | I01.019 | rhodniin inhibitor unit 1 | complex with cattle thrombin | 1TBQ_R |
IA | I01.019 | rhodniin inhibitor unit 1 | complex with cattle thrombin | 1TBR_R |
IA | I01.021 | tryptase inhibitor (Hirudo medicinalis) | complex with pig trypsin | 1AN1_I |
IA | I01.021 | tryptase inhibitor (Hirudo medicinalis) | complex with pig trypsin | 1LDT_L |
IA | I01.021 | tryptase inhibitor (Hirudo medicinalis) | 2KMO | |
IA | I01.021 | tryptase inhibitor (Hirudo medicinalis) | 2KMP | |
IA | I01.021 | tryptase inhibitor (Hirudo medicinalis) | 2KMQ | |
IA | I01.021 | tryptase inhibitor (Hirudo medicinalis) | 2KMR | |
IA | I01.023 | dipetalogastin inhibitor unit 3 | NMR structure | 1KMA |
IA | I01.048 | CrSPI-1 unit 2 (Carcinoscorpius rotundicauda) | complex with subtilisin Carlsberg | 3QTL_D |
IA | I01.056 | AaTI (Aedes aegypti) | kazal type inhibitor from salivary glands of aedes aegypti mosquito | 5DAE_A |
IA | I01.057 | esophagus cancer-related gene-2 | 2LEO | |
IA | I01.058 | infestin 1R | infestin 4 | 2ERW_A |
IA | I01.059 | greglin | complex with subtilisn | 4GI3 |
IA | I01.950 | SPINK5 inhibitor unit 2 | NMR structure; domain six only | 1H0Z_A |
IA | I01.962 | dipetalogastin unit 1-2 | 1KMA_A | |
IA | I01.966 | follistatin | 2B0U | |
IA | I01.966 | follistatin | 2P6A | |
IA | I01.966 | follistatin | 3HH2 | |
IA | I01.966 | follistatin | complex with gdf11 | 5JHW_C |
IA | I01.966 | follistatin | 1LR7 | |
IA | I01.966 | follistatin | 1LR8 | |
IA | I01.966 | follistatin | 1LR9 | |
IA | I01.966 | follistatin | 2ARP | |
IA | I01.968 | follistatin-related protein 3 | 2KCX | |
IA | I01.968 | follistatin-related protein 3 | 3B4V | |
IA | I01.968 | follistatin-related protein 3 | 3SEK | |
IA | I01.970 | SPINK4 protein | NMR structure | 1PCE |
IA | I01.978 | Tmeff2 protein | 2FMW | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | NMR structure | 1IY5 |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | NMR structure; Pro14Cys and Asn39Cys engineered form | 1IY6 |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | complex with LRP4 | 3V64 |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | complex with LRP4 | 3V65 |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 4HGU | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | NMR structure of C state | 1M8B |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | NMR structure of T state | 1M8C |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 1BMO | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 1NUB | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 1SRA | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 2V53 | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 3MRR | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | laminin-binding domain | 1JB3 |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | laminin-binding domain | 1JC7 |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 1PXU | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 1PZ7 | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 1PZ8 | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 1PZ9 | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | NMR structure; B0 isoform of G3 domain in calcium bound state | 1Q56 |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 3I70 | |
IA | I01.UPW | family I1 unassigned peptidase inhibitors | 3PIS | |
IB | I02.001 | aprotinin | 30-51 disulfide mutant | 1AAL |
IB | I02.001 | aprotinin | 1B0C | |
IB | I02.001 | aprotinin | homodecamer | 1BHC |
IB | I02.001 | aprotinin | 1BPI | |
IB | I02.001 | aprotinin | Tyr23Ala mutant | 1BPT |
IB | I02.001 | aprotinin | variant, complex with rat anionic trypsin I variant | 1BRB_I |
IB | I02.001 | aprotinin | complex with human thrombin | 1BTH_P |
IB | I02.001 | aprotinin | Phe22Ala mutant | 1BTI |
IB | I02.001 | aprotinin | 1BZ5 | |
IB | I02.001 | aprotinin | 1BZX_I | |
IB | I02.001 | aprotinin | complex with chymotrypsin A | 1CBW_D |
IB | I02.001 | aprotinin | complex with rat anionic trypsin | 1CO7_I |
IB | I02.001 | aprotinin | complex with soft tick anticoagluant protein | 1D0D_B |
IB | I02.001 | aprotinin | 1EAW_B | |
IB | I02.001 | aprotinin | 1EJM_B | |
IB | I02.001 | aprotinin | 1F5R_I | |
IB | I02.001 | aprotinin | 1F7Z_I | |
IB | I02.001 | aprotinin | complex with tissue factor and coagulation factor VII | 1FAK_I |
IB | I02.001 | aprotinin | Phe45Ala mutant | 1FAN |
IB | I02.001 | aprotinin | 1FY8_I | |
IB | I02.001 | aprotinin | Ala11Thr, Ala13Pro, Arg15Lys and Leu52Met mutant | 1G6X |
IB | I02.001 | aprotinin | NMR structure; Gly37Ala mutant | 1JV8 |
IB | I02.001 | aprotinin | NMR structure; Gly37Ala mutant | 1JV9 |
IB | I02.001 | aprotinin | NMR structure; synthetic BetaCore peptide | 1K09 |
IB | I02.001 | aprotinin | cyclic form | 1K6U |
IB | I02.001 | aprotinin | NMR structure; Ala16Val mutant | 1LD5 |
IB | I02.001 | aprotinin | NMR structure; 8A mutant | 1LD6 |
IB | I02.001 | aprotinin | complex with chymotrypsin A | 1MTN_D |
IB | I02.001 | aprotinin | Asn43Gly mutant | 1NAG |
IB | I02.001 | aprotinin | 1OA5 | |
IB | I02.001 | aprotinin | 1OA6 | |
IB | I02.001 | aprotinin | structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin | 1P2I_I |
IB | I02.001 | aprotinin | structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin | 1P2J_I |
IB | I02.001 | aprotinin | structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin | 1P2K_I |
IB | I02.001 | aprotinin | complex with chymotrypsin A | 1P2M_B |
IB | I02.001 | aprotinin | complex with chymotrypsin A | 1P2N_B |
IB | I02.001 | aprotinin | comlex with chymotrypsin A | 1P2O_B |
IB | I02.001 | aprotinin | complex with chymotrypsin A | 1P2Q_B |
IB | I02.001 | aprotinin | NMR structure | 1PIT |
IB | I02.001 | aprotinin | Ala11Thr, Ala13Pro, Arg15Lys and Leu52Met mutant | 1QLQ |
IB | I02.001 | aprotinin | P1 Glu mutant; complex with chymotrypsin A | 1T7C_B |
IB | I02.001 | aprotinin | P1 Met mutant; complex with chymotrypsin A | 1T8L_B |
IB | I02.001 | aprotinin | P1 His mutant; complex with chymotrypsin A | 1T8M_B |
IB | I02.001 | aprotinin | P1 Thr mutant; complex with chymotrypsin A | 1T8N_B |
IB | I02.001 | aprotinin | P1 Trp mutant; complex with chymotrypsin A | 1T8O_B |
IB | I02.001 | aprotinin | complex with anhydro-trypsin | 1TPA_I |
IB | I02.001 | aprotinin | NMR structure | 1UUA |
IB | I02.001 | aprotinin | NMR structure | 1UUB |
IB | I02.001 | aprotinin | mutant; complex with trypsin | 1YKT_B |
IB | I02.001 | aprotinin | mutant; complex with trypsin | 1YLC_B |
IB | I02.001 | aprotinin | mutant; complex with trypsin | 1YLD_B |
IB | I02.001 | aprotinin | Cys14Ser, Cys38Ser variant; complex with trypsin | 2FI3_I |
IB | I02.001 | aprotinin | Cys14Ser variant; complex with trypsin | 2FI4_I |
IB | I02.001 | aprotinin | Cys38Ser variant; complex with trypsin | 2FI5_I |
IB | I02.001 | aprotinin | complex with trypsin | 2FTL_I |
IB | I02.001 | aprotinin | Tyr35Gly variant; complex with trypsin | 2FTM_B |
IB | I02.001 | aprotinin | decamer | 2HEX |
IB | I02.001 | aprotinin | complex with West Nile virus NS2B-NS3 proteins | 2IJO_I |
IB | I02.001 | aprotinin | complex with pig tissue kallikrein | 2KAI_I |
IB | I02.001 | aprotinin | complex with cattle cationic trypsin | 2PTC_I |
IB | I02.001 | aprotinin | complex with human mesotrypsin | 2R9P_I |
IB | I02.001 | aprotinin | human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (bpti) | 2RA3_I |
IB | I02.001 | aprotinin | complex with cattle cationic trypsinogen | 2TGP_I |
IB | I02.001 | aprotinin | complex with cattle cationic trypsinogen | 2TPI_I |
IB | I02.001 | aprotinin | 2ZJX | |
IB | I02.001 | aprotinin | 2ZVX | |
IB | I02.001 | aprotinin | 3BTD_I | |
IB | I02.001 | aprotinin | 3BTE_I | |
IB | I02.001 | aprotinin | 3BTF_I | |
IB | I02.001 | aprotinin | 3BTG_I | |
IB | I02.001 | aprotinin | 3BTH_I | |
IB | I02.001 | aprotinin | 3BTK_I | |
IB | I02.001 | aprotinin | 3BTM_I | |
IB | I02.001 | aprotinin | 3BTQ_I | |
IB | I02.001 | aprotinin | 3BTT_I | |
IB | I02.001 | aprotinin | 3BTW_I | |
IB | I02.001 | aprotinin | complex with anionic trypsin | 3FP6_I |
IB | I02.001 | aprotinin | cleaved form (Lys15+Ala16); complex with anionic trypsin mutant Ser195Ala | 3FP7_I |
IB | I02.001 | aprotinin | complex with anionic trypsin mutant Ser195Ala | 3FP8_I |
IB | I02.001 | aprotinin | complex with prostasin | 3GYM_I |
IB | I02.001 | aprotinin | 3LDI | |
IB | I02.001 | aprotinin | 3LDJ | |
IB | I02.001 | aprotinin | 3LDM | |
IB | I02.001 | aprotinin | 3OTJ_I | |
IB | I02.001 | aprotinin | 3P92 | |
IB | I02.001 | aprotinin | 3P95 | |
IB | I02.001 | aprotinin | complex with rat anionic trypsin II | 3TGI_I |
IB | I02.001 | aprotinin | complex with rat anionic trypsin II, Ser195Ala mutant | 3TGJ_I |
IB | I02.001 | aprotinin | 3TGK_I | |
IB | I02.001 | aprotinin | complex with cattle cationic trypsinogen | 3TPI_I |
IB | I02.001 | aprotinin | 3U1J | |
IB | I02.001 | aprotinin | 3WNY | |
IB | I02.001 | aprotinin | 4BNR | |
IB | I02.001 | aprotinin | 4DG4 | |
IB | I02.001 | aprotinin | 4PTI | |
IB | I02.001 | aprotinin | complex with cattle cationic trypsinogen | 4TPI_I |
IB | I02.001 | aprotinin | 4WWY | |
IB | I02.001 | aprotinin | 4WXV | |
IB | I02.001 | aprotinin | 4Y0Y_I | |
IB | I02.001 | aprotinin | 4Y0Z_I | |
IB | I02.001 | aprotinin | 4Y10_I | |
IB | I02.001 | aprotinin | 4Y11_I | |
IB | I02.001 | aprotinin | a simplified bpti variant containing 21 alanines out of 58 residues | 5JB4_A |
IB | I02.001 | aprotinin | a simplified bpti variant containing 22 alanines out of 58 residues | 5JB5_A |
IB | I02.001 | aprotinin | a simplified bpti variant containing 23 alanines out of 58 residues | 5JB6_A |
IB | I02.001 | aprotinin | a simplified bpti variant containing 24 alanines out of 58 residues | 5JB7_A |
IB | I02.001 | aprotinin | crystal form II | 5PTI |
IB | I02.001 | aprotinin | Cys14Gly/Ala38Leu mutant | 5XX2_A |
IB | I02.001 | aprotinin | Cys14Gly/Ala38Gly mutant | 5XX3_A |
IB | I02.001 | aprotinin | Cys14Gly/Ala38Lys mutant | 5XX4_A |
IB | I02.001 | aprotinin | Cys14Gly/Ala38Ile mutant | 5XX5_A |
IB | I02.001 | aprotinin | hetero-micro-seeding: crystal structure of bpti-[5,55]c14ga38i variantusing micro-seeds from -c14ga38g variant | 5XX6_A |
IB | I02.001 | aprotinin | hetero-micro-seeding: crystal structure of bpti-[5,55]c14ga38i variantusing micro-seeds from -c14ga38i variant | 5XX7_A |
IB | I02.001 | aprotinin | hetero-micro-seeding: crystal structure of bpti-[555]c14ga38i variant using micro-seeds from -c14ga38l variant | 5XX8_A |
IB | I02.001 | aprotinin | crystal structures of unlinked full length ns3 from dengue virus provide insights into dynamics of protease domain | 5YVU_I |
IB | I02.001 | aprotinin | complex with full length ns3 protein (ed4ns2bns3) | 5YW1_I |
IB | I02.001 | aprotinin | the methylene thioacetal bpti (bovine pancreatic trypsin inhibitor) mutant structure | 6F1F_A |
IB | I02.001 | aprotinin | 6PTI | |
IB | I02.001 | aprotinin | Cys30Ala, Cys51Ala mutant | 7PTI |
IB | I02.001 | aprotinin | Tyr35Gly mutant | 8PTI |
IB | I02.001 | aprotinin | Tyr35Gly mutant | 9PTI |
IB | I02.005 | bikunin inhibitor unit 1 | 1BIK_A | |
IB | I02.006 | bikunin inhibitor unit 2 | 1BIK_B | |
IB | I02.006 | bikunin inhibitor unit 2 | lipocalin domain | 3QKG |
IB | I02.006 | bikunin inhibitor unit 2 | 4ES7 | |
IB | I02.006 | bikunin inhibitor unit 2 | domain 2; complex with human mesotrypsin | 4U30 |
IB | I02.007 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 1 | first Kunitz domain; complex with human hepatocyte growth factor activator | 1YC0_I |
IB | I02.007 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 1 | complex with matriptase peptidase domain | 4ISL_B |
IB | I02.007 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 1 | complex with matriptase peptidase domain | 4ISN_B |
IB | I02.007 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 1 | complex with matriptase peptidase unit | 4ISO_B |
IB | I02.008 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 2 | 2MSX | |
IB | I02.008 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 2 | 4ISL | |
IB | I02.008 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 2 | 4ISN | |
IB | I02.008 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 2 | 4ISO | |
IB | I02.008 | hepatocyte growth factor activator inhibitor 1 inhibitor unit 2 | structure of full-length extracellular domain of hai-1 at ph 4.6 | 5H7V_A |
IB | I02.010 | hepatocyte growth factor activator inhibitor 2 inhibitor unit 2 | 4U32 | |
IB | I02.011 | tissue factor pathway inhibitor-1 inhibitor unit 1 | NMR structure | 1ADZ |
IB | I02.011 | tissue factor pathway inhibitor-1 inhibitor unit 1 | NMR structure; third Kunitz domain | 1IRH |
IB | I02.011 | tissue factor pathway inhibitor-1 inhibitor unit 1 | complex with pig trypsin | 1TFX_C |
IB | I02.013 | tissue factor pathway inhibitor-2 inhibitor unit 1 | domain 1; complex with bovine trypsin | 1ZR0_B |
IB | I02.015 | protease nexin-2 | inhibitor domain | 1AAP |
IB | I02.015 | protease nexin-2 | NMR structure of residues 1-28 | 1AMB |
IB | I02.015 | protease nexin-2 | NMR structure of residues 1-28 | 1AMC |
IB | I02.015 | protease nexin-2 | NMR structure of residues 1-40 | 1AML |
IB | I02.015 | protease nexin-2 | NMR structure of residues 1-40 | 1BA4 |
IB | I02.015 | protease nexin-2 | NMR structure of residues 1-40 | 1BA6 |
IB | I02.015 | protease nexin-2 | NMR structure of residues 1-28 | 1BJB |
IB | I02.015 | protease nexin-2 | NMR structure of residues 1-28 | 1BJC |
IB | I02.015 | protease nexin-2 | complex with rat trypsin variant | 1BRC_I |
IB | I02.015 | protease nexin-2 | Complex with bovine chymotrypsin | 1CA0_D |
IB | I02.015 | protease nexin-2 | NMR structure of residues 10-35 | 1HZ3 |
IB | I02.015 | protease nexin-2 | N-terminal domain | 1MWP |
IB | I02.015 | protease nexin-2 | NMR structure of residues 25-35 | 1QCM |
IB | I02.015 | protease nexin-2 | complex with cattle cationic trypsin | 1TAW_B |
IB | I02.015 | protease nexin-2 | complex with coagulation factor XI catalytic domain | 1ZJD_B |
IB | I02.015 | protease nexin-2 | complex with human mesotrypsin | 3L33_E |
IB | I02.015 | protease nexin-2 | complex with human presequence protease | 4NGE_B |
IB | I02.015 | protease nexin-2 | amyloid-beta 4-10; complex with angiotensin-1 converting enzyme N- domain | 5AM8_P |
IB | I02.015 | protease nexin-2 | amyloid-beta 35-42; complex with angiotensin-1 converting enzyme N- domain | 5AMB_P |
IB | I02.015 | protease nexin-2 | human mesotrypsin in complex with amyloid precursor protein inhibitor variant appi-m17g/i18f/f34v | 5C67_E |
IB | I02.015 | protease nexin-2 | combinatorial engineering of proteolytically resistant appi variants that selectively inhibit human kallikrein 6 for cancer therapy | 5NX1_B |
IB | I02.015 | protease nexin-2 | combinatorial engineering of proteolytically resistant appi variants that selectively inhibit human kallikrein 6 for cancer therapy | 5NX3_B |
IB | I02.015 | protease nexin-2 | appi variant Thr11Val/Met17Arg/Ile18Phe/Phe34Val; complex with human mesotrypsin | 6GFI_E |
IB | I02.015 | protease nexin-2 | recognition of the amyloid precursor protein by human gamma-secretase | 6IYC_E |
IB | I02.015 | protease nexin-2 | NMR structure | 2ROZ |
IB | I02.015 | protease nexin-2 | NMR structure | 2YSZ |
IB | I02.015 | protease nexin-2 | NMR structure | 2YT0 |
IB | I02.015 | protease nexin-2 | NMR structure | 2YT1 |
IB | I02.015 | protease nexin-2 | complex with DR6 CRD domain | 4YN0 |
IB | I02.015 | protease nexin-2 | NGYENPTYK peptide; complex with PTB domain of mouse Disabled homolog 1 | 1M7E |
IB | I02.015 | protease nexin-2 | NMR structure; amyloid beta-peptide 28mer | 1NMJ |
IB | I02.015 | protease nexin-2 | 9mer peptide; complex with PTB domain of mouse Disabled homolog 1 | 1OQN |
IB | I02.015 | protease nexin-2 | NMR structure | 2LI9 |
IB | I02.016 | amyloid precursor-like protein 2 | mesotrypsin in complex with cleaved amyloid precursor like protein 2 inhibitor (aplp2) | 5JBT_X |
IB | I02.020 | boophilin inhibitor unit 1 | complex with thrombin | 2ODY |
IB | I02.021 | boophilin inhibitor unit 2 | complex with thrombin | 2ODY |
IB | I02.024 | ornithodorin inhibitor unit 1 | complex with bovine thrombin | 1TOC_R |
IB | I02.031 | fraction IX inhibitor (Bungarus fasciatus) | 1JC6 | |
IB | I02.032 | ornithodorin inhibitor unit 2 | complex with bovine thrombin | 1TOC_R |
IB | I02.052 | textilinin-1 (Pseudonaja textilis) | 3BYB_A | |
IB | I02.052 | textilinin-1 (Pseudonaja textilis) | complex with trypsin | 3D65_I |
IB | I02.052 | textilinin-1 (Pseudonaja textilis) | 3UIR_C | |
IB | I02.052 | textilinin-1 (Pseudonaja textilis) | textilinin-1, a kunitz-type serine protease inhibitor from pichia expression system | 5ZJ3_A |
IB | I02.053 | TdPI tryptase inhibitor (Rhipicephalus appendiculatus) | structure of the tryptase inhibitor tdpi from a tick | 2UUX_A |
IB | I02.056 | HWTI trypsin inhibitor (Ornithoctonus huwena) | NMR structure | 1DTK |
IB | I02.056 | HWTI trypsin inhibitor (Ornithoctonus huwena) | NMR structure | 1BF0 |
IB | I02.056 | HWTI trypsin inhibitor (Ornithoctonus huwena) | 5YV7_A | |
IB | I02.056 | HWTI trypsin inhibitor (Ornithoctonus huwena) | NMR structure | 2JOT |
IB | I02.061 | Kunitz inhibitor (Heteractis crispa-type) | NMR structure | 1SHP |
IB | I02.065 | chymotrypsin inhibitor (Naja atra) | 2M99 | |
IB | I02.950 | tissue factor pathway inhibitor-1 unit 3 | 1IRH_A | |
IB | I02.950 | tissue factor pathway inhibitor-1 unit 3 | 4BQD | |
IB | I02.950 | tissue factor pathway inhibitor-1 unit 3 | 4DTG | |
IB | I02.950 | tissue factor pathway inhibitor-1 unit 3 | crystal structure of 2f22 fab fragment against tfpi1 | 5NMV_L |
IB | I02.950 | tissue factor pathway inhibitor-1 unit 3 | human mesotrypsin (prss3) complex with tissue factor pathway inhibitor variant (tfpi1-kd1-k15r-i17c-i34c) | 6BX8_B |
IB | I02.953 | WFIKKN peptidase inhibitor inhibitor unit 2 | 2DDI | |
IB | I02.953 | WFIKKN peptidase inhibitor inhibitor unit 2 | 2DDJ | |
IB | I02.954 | WFIKKNRP putative peptidase inhibitor unit 2 | wfikkn2 follistatin domain | 6MAA_A |
IB | I02.968 | collagen alpha 3(VI) chain | 1KNT_A | |
IB | I02.968 | collagen alpha 3(VI) chain | Kunitz type domain C5 | 1KTH_A |
IB | I02.968 | collagen alpha 3(VI) chain | NMR structure; Kunitz domain only | 1KUN_A |
IB | I02.968 | collagen alpha 3(VI) chain | Kunitz type domain C5 | 2KNT_A |
IB | I02.968 | collagen alpha 3(VI) chain | 1KNT | |
IB | I02.968 | collagen alpha 3(VI) chain | 1KTH | |
IB | I02.968 | collagen alpha 3(VI) chain | 1KUN | |
IB | I02.968 | collagen alpha 3(VI) chain | 2KNT | |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | NMR structure | 1DEM |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | NMR structure | 1DEN |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | 1DTX | |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | complex with human thrombin | 1E0F_I |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | 1BUN | |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | 4BD9 | |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | 4NTW | |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | 4NTX | |
IB | I02.UPW | family I2 unassigned peptidase inhibitors | 4NTY | |
IC | I03.001 | soybean Kunitz trypsin inhibitor | 1AVU | |
IC | I03.001 | soybean Kunitz trypsin inhibitor | orthorhombic crystal form, complex with pig trypsin | 1AVW_B |
IC | I03.001 | soybean Kunitz trypsin inhibitor | tetragonal crystal form, complex with pig trypsin | 1AVX_B |
IC | I03.001 | soybean Kunitz trypsin inhibitor | 1BA7 | |
IC | I03.001 | soybean Kunitz trypsin inhibitor | complex with 1,5-disulfonyl naphthalene | 6NTT_A |
IC | I03.003 | alocasin | crystal structure of bifunctional kunitz type trypsin /amylase inhibitor (amtin) from the tubers of alocasia macrorrhiza ***caveat 5wvx residues gly b 37 and cys b 39 are linked. however, there is ***caveat 2 5wvx a residue between them in the polymeric s | 5WVX_A |
IC | I03.003 | alocasin | 5YCZ | |
IC | I03.004 | alpha-amylase/subtilisin inhibitor (Hordeum-type) | complex with alpha-amylase | 1AVA_C |
IC | I03.004 | alpha-amylase/subtilisin inhibitor (Hordeum-type) | thioredoxin h2 (hvtrxh2) in a mixed disulfide complex with the target protein basi | 2IWT_B |
IC | I03.004 | alpha-amylase/subtilisin inhibitor (Hordeum-type) | complex with subtilisin savinase | 3BX1_C |
IC | I03.004 | alpha-amylase/subtilisin inhibitor (Hordeum-type) | structure and function study of rice bifunctional alpha- amylase/subtilisin inhibitor from oryza sativa | 2QN4_A |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 1EYL | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | Asn14Lys mutant | 1FMZ |
IC | I03.009 | winged-bean chymotrypsin inhibitor | Asn14Asp mutant | 1FN0 |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 1WBC | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | p1 mutant (Leu to Arg) | 1XG6_A |
IC | I03.009 | winged-bean chymotrypsin inhibitor | Asn14Gly mutant | 2BEA_A |
IC | I03.009 | winged-bean chymotrypsin inhibitor | Asn toThr mutant | 2BEB_A |
IC | I03.009 | winged-bean chymotrypsin inhibitor | Asn to Gln mutant | 2ESU_A |
IC | I03.009 | winged-bean chymotrypsin inhibitor | Asn to Ala mutant | 2ET2_A |
IC | I03.009 | winged-bean chymotrypsin inhibitor | complex with bovine trypsin | 2QYI_B |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 2WBC | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 3I29_B | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 3I2A | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 3I2X | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 3QYD | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 3VEQ_A | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 3WBC | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 4H9W | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 4HA2 | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 4TLP | |
IC | I03.009 | winged-bean chymotrypsin inhibitor | 4WBC | |
IC | I03.011 | Erythrina-type trypsin/tissue plasminogen activator inhibitor | 1TIE | |
IC | I03.012 | cruzipain inhibitor (Bauhinia bauhinioides) | 2GZB | |
IC | I03.016 | Bauhinia trypsin/plasma kallikrein inhibitor | Leu55Arg mutant; complex with bovine trypsin | 6DWF_G |
IC | I03.016 | Bauhinia trypsin/plasma kallikrein inhibitor | crystal with bovine trypsin | 6DWH_G |
IC | I03.020 | potato Kunitz-type trypsin inhibitor | crystal structure of potato serine protease inhibitor. | 3TC2_A |
IC | I03.021 | Kunitz serine peptidase inhibitor (Delonix regia) | 1R8N | |
IC | I03.022 | latex serine peptidase inhibitor (Papaya carica) | 3S8J | |
IC | I03.022 | latex serine peptidase inhibitor (Papaya carica) | 3S8K | |
IC | I03.024 | Leucaena-type trypsin inhibitor (Fabaceae) | theoretical model; alpha and beta chains; complex with pig trypsin | 1LT2_B |
IC | I03.025 | Kunitz subtilisin inhibitor (Fabaceae-type) | crystal structure of a kunitz type trypsin inhibitor from cicer arietinuml | 5XOZ_A |
IC | I03.025 | Kunitz subtilisin inhibitor (Fabaceae-type) | 6JBP | |
IC | I03.028 | crucifer cysteine peptidase inhibitor | type ii water soluble chl binding proteins | 5HPZ_A |
IC | I03.030 | inhibitor MtTi2 (Medicago truncatulata) | miraculin-like protein from vitis vinifera | 5YH4_A |
IC | I03.030 | inhibitor MtTi2 (Medicago truncatulata) | crystal structure of miraculin like protein from seeds of murraya koenigii | 3IIR_A |
IC | I03.030 | inhibitor MtTi2 (Medicago truncatulata) | crystal structure of murraya koenigii miraculin-like protein at 2.2 a resolution at ph 7.0 | 3ZC8_A |
IC | I03.030 | inhibitor MtTi2 (Medicago truncatulata) | crystal structure of murraya koenigii miraculin-like protein at 2.2 a resolution at ph 4.6 | 3ZC9_A |
IC | I03.034 | tamarind Kunitz trypsin inhibitor (Tamarindus indica) | 1R8O_A | |
IC | I03.034 | tamarind Kunitz trypsin inhibitor (Tamarindus indica) | kuntiz type trypsin inhibitor with factor xa inhibitory activity | 4AN6_A |
IC | I03.034 | tamarind Kunitz trypsin inhibitor (Tamarindus indica) | kunitz type trypsin inhibitor complex with porcine trypsin | 4AN7_B |
IC | I03.UPA | subfamily I3A unassigned peptidase inhibitors | 1WBA | |
IC | I03.UPA | subfamily I3A unassigned peptidase inhibitors | 2DRE_A | |
IC | I03.UPA | subfamily I3A unassigned peptidase inhibitors | water-soluble chlorophyll protein (wscp) from lepidium virginicum (mutation l91p) with chlorophyll-a | 6GIW_A |
IC | I03.UPA | subfamily I3A unassigned peptidase inhibitors | water-soluble chlorophyll protein (wscp) from lepidium virginicum (mutation l91p) with chlorophyll-b ***caveat 6gix chl a 1001 has wrong chirality at atom c8 chl b 1001 has ***caveat 2 6gix wrong chirality at atom c8 chl c 1001 has wrong chirality ***cave | 6GIX_A |
IC | I03.UPA | subfamily I3A unassigned peptidase inhibitors | 1R8O_B | |
IC | I03.UPA | subfamily I3A unassigned peptidase inhibitors | 4ZOT | |
ID | I04.001 | alpha-1-peptidase inhibitor | uncleaved | 1ATU |
ID | I04.001 | alpha-1-peptidase inhibitor | cleaved antitrypsin polymer | 1D5S_A |
ID | I04.001 | alpha-1-peptidase inhibitor | uncleaved form | 1HP7 |
ID | I04.001 | alpha-1-peptidase inhibitor | engineered form | 1IZ2 |
ID | I04.001 | alpha-1-peptidase inhibitor | uncleaved | 1KCT |
ID | I04.001 | alpha-1-peptidase inhibitor | native A1PI-Pittsburgh | 1OO8_A |
ID | I04.001 | alpha-1-peptidase inhibitor | non-covalent complex between alpha-1-pi-pittsburgh and s195a trypsin | 1OPH_A |
ID | I04.001 | alpha-1-peptidase inhibitor | Phe51Leu mutant | 1PSI |
ID | I04.001 | alpha-1-peptidase inhibitor | uncleaved | 1QLP |
ID | I04.001 | alpha-1-peptidase inhibitor | cleaved alpha-1-antitrypsin polymer | 1QMB_A |
ID | I04.001 | alpha-1-peptidase inhibitor | complex with pig elastase-1 | 2D26_A |
ID | I04.001 | alpha-1-peptidase inhibitor | crystal form a | 2QUG_A |
ID | I04.001 | alpha-1-peptidase inhibitor | crystal form b | 3CWL_A |
ID | I04.001 | alpha-1-peptidase inhibitor | complex with citrate | 3CWM_A |
ID | I04.001 | alpha-1-peptidase inhibitor | Tthr114Phe mutant | 3DRM_A |
ID | I04.001 | alpha-1-peptidase inhibitor | Gly117Phe mutant | 3DRU_A |
ID | I04.001 | alpha-1-peptidase inhibitor | cleaved antitrypsin with P10 Pro, and P9-p6 Asp | 3NDD_A |
ID | I04.001 | alpha-1-peptidase inhibitor | cleaved antitrypsin with P8-P6 Asp | 3NDF_A |
ID | I04.001 | alpha-1-peptidase inhibitor | intact native wild-type | 3NE4_A |
ID | I04.001 | alpha-1-peptidase inhibitor | crystal structure of an alpha-1-antitrypsin trimer | 3T1P_A |
ID | I04.001 | alpha-1-peptidase inhibitor | a1at:ttai ternary complex | 4PYW_A |
ID | I04.001 | alpha-1-peptidase inhibitor | crystal structure of recombinant human z alpha-1-antitrypsin | 5IO1_A |
ID | I04.001 | alpha-1-peptidase inhibitor | crystal structure of native alpha-1-antitrypsin with seven stabilisingmutations | 5NBU_A |
ID | I04.001 | alpha-1-peptidase inhibitor | crystal structure of native alpha-1-antitrypsin with seven stabilisingmutations | 5NBV_A |
ID | I04.001 | alpha-1-peptidase inhibitor | cleaved | 7API |
ID | I04.001 | alpha-1-peptidase inhibitor | cleaved | 8API |
ID | I04.001 | alpha-1-peptidase inhibitor | cleaved | 9API |
ID | I04.002 | alpha-1-antichymotrypsin | Ala249Arg mutant; cleaved form | 1AS4 |
ID | I04.002 | alpha-1-antichymotrypsin | alpha1-antichymotrypsin serpin in the delta conformation (partial loop insertion) | 1QMN_A |
ID | I04.002 | alpha-1-antichymotrypsin | Cleaved form | 2ACH |
ID | I04.002 | alpha-1-antichymotrypsin | Ala347Arg mutant; cleaved form | 3CAA |
ID | I04.002 | alpha-1-antichymotrypsin | 3DLW_A | |
ID | I04.002 | alpha-1-antichymotrypsin | Thr345Arg mutant; cleaved form | 4CAA |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant dbs-i1: a drug- binding serpin for doxycycline | 5OM2_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant dbs-i5: a mmp14- cleavable drug-binding serpin for doxycycline | 5OM3_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant dbs-i-allo1: an allosterically triggered drug-binding serpin for doxycycline | 5OM5_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant dbs-i-allo2: a mmp9-cleavable drug-binding serpin for doxycycline | 5OM6_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant dbs-ii: a drug- binding serpin for doxorubicin | 5OM7_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal form 2 of alpha1-antichymotrypsin variant dbs-ii-allo: an allosterically modulated drug-binding serpin for doxorubicin | 5OM8_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal form 1 of alpha1-antichymotrypsin variant dbs-ii-allo: an allosterically modulated drug-binding serpin for doxorubicin | 6FTP_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant newbg-0: a new binding globulin variant that is devoid of any cortisol-binding capabilities | 6HGD_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant newbg-i in the uncleaved s-conformation | 6HGE_A |
ID | I04.002 | alpha-1-antichymotrypsin | variant newbg-II; complex with cortisol | 6HGF_A |
ID | I04.002 | alpha-1-antichymotrypsin | variant newbg-III; complex with cortisol | 6HGG_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant newbg-iii: a new binding globulin without any bound ligand | 6HGH_A |
ID | I04.002 | alpha-1-antichymotrypsin | variant newbg-III; complex with corticosterone | 6HGI_A |
ID | I04.002 | alpha-1-antichymotrypsin | variant newbg-III; complex with aldosterone | 6HGJ_A |
ID | I04.002 | alpha-1-antichymotrypsin | variant newbg-III; complex with progesterone | 6HGK_A |
ID | I04.002 | alpha-1-antichymotrypsin | variant newbg-III; complex with testosterone | 6HGL_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant newbg-iii-allo: an allosterically controlled new binding globulin with an unprecedentedly high ligand release efficacy | 6HGM_A |
ID | I04.002 | alpha-1-antichymotrypsin | crystal structure of alpha1-antichymotrypsin variant dbs-ii-allo-l55v:an allosterically controlled doxorubicin-binding serpin with an unprecedentedly high ligand release efficacy | 6HGN_A |
ID | I04.003 | kallistatin | crystal structure of human glycosylated kallistatin at 3.0 angstrom resolution | 6F02_A |
ID | I04.003 | kallistatin | crystal structure of reactive loop cleaved kallistatin at 1.9 angstromresolution | 6F4U_A |
ID | I04.003 | kallistatin | crystal structure of cleaved kallistatin complex with heparin at 1.8angstrom resolution | 6F4V_A |
ID | I04.004 | protein C inhibitor | cleaved form | 1LQ8 |
ID | I04.004 | protein C inhibitor | theoretical model | 1PAI |
ID | I04.004 | protein C inhibitor | 2HI9 | |
ID | I04.004 | protein C inhibitor | 2OL2 | |
ID | I04.004 | protein C inhibitor | theoretical model | 2PAI |
ID | I04.004 | protein C inhibitor | cleaved form; complex with heparin | 3DY0_A |
ID | I04.004 | protein C inhibitor | 3B9F | |
ID | I04.005 | protein Z-dependent peptidase inhibitor | 3F1S_A | |
ID | I04.005 | protein Z-dependent peptidase inhibitor | 3H5C_A | |
ID | I04.005 | protein Z-dependent peptidase inhibitor | 4AFX | |
ID | I04.005 | protein Z-dependent peptidase inhibitor | 4AJU | |
ID | I04.005 | protein Z-dependent peptidase inhibitor | H-77; complex with endothiapepsin | 1ER8 |
ID | I04.005 | protein Z-dependent peptidase inhibitor | 4AJT | |
ID | I04.006 | serpin B1 | Cleaved form | 1HLE |
ID | I04.006 | serpin B1 | 4GA7 | |
ID | I04.007 | plasminogen activator inhibitor 2 | Deletion of mutant of residues 66-98 | 1BY7 |
ID | I04.007 | plasminogen activator inhibitor 2 | loop (66-98) deletion mutant; complex with peptide mimicking the reactive center loop | 1JRR_A |
ID | I04.007 | plasminogen activator inhibitor 2 | human plasminogen activator inhibitor-2.[loop (66-98) deletion mutant] complexed with peptide n-acetyl- teaaagdggvmtgr-oh | 2ARQ_A |
ID | I04.007 | plasminogen activator inhibitor 2 | human plasminogen activator inhibitor-2.[loop (66-98) deletion mutant] complexed with peptide n-acetyl- teaaagmggvmtgr-oh | 2ARR_A |
ID | I04.008 | squamous cell carcinoma antigen 1 | crystal structure of human squamous cell carcinoma antigen 1 | 2ZV6_A |
ID | I04.008 | squamous cell carcinoma antigen 1 | psoriasis pathogenesis - pso p27 constitute a compact structure forming large aggregates. high ph structure | 4ZK0_A |
ID | I04.008 | squamous cell carcinoma antigen 1 | psoriasis pathogenesis - pso p27 constitute a compact structure forming large aggregates. low ph structure | 4ZK3_A |
ID | I04.018 | antithrombin | cleaved form | 1ATT |
ID | I04.018 | antithrombin | dimer | 1ANT |
ID | I04.018 | antithrombin | 1ATH | |
ID | I04.018 | antithrombin | complex with pentasaccharide | 1AZX |
ID | I04.018 | antithrombin | binary complex | 1BR8 |
ID | I04.018 | antithrombin | 1DZG | |
ID | I04.018 | antithrombin | p14-fluorescein-n135q-s380c-antithrombin-iii | 1DZH_L |
ID | I04.018 | antithrombin | complex with pentasaccharide | 1E03_L |
ID | I04.018 | antithrombin | 1E04 | |
ID | I04.018 | antithrombin | 1E05 | |
ID | I04.018 | antithrombin | complex with a P14-P8 reactive loop peptide, and an exogenous tetrapeptide | 1JVQ_L |
ID | I04.018 | antithrombin | dimeric form; complex with a P14-P9 reactive loop peptide and an exogenous tripeptide | 1LK6_L |
ID | I04.018 | antithrombin | pentasaccharide-bound intermediate state | 1NQ9_I |
ID | I04.018 | antithrombin | P13 alanine variant | 1OYH_I |
ID | I04.018 | antithrombin | structure of dimeric antithrombin complexed with a p14-p9 reactive loop peptide and an exogenous tripeptide (formyl- norleucine-lf) | 1R1L_L |
ID | I04.018 | antithrombin | antithrombin-anhydrothrombin-heparin ternary complex structure | 1SR5_A |
ID | I04.018 | antithrombin | monomeric form | 1T1F_A |
ID | I04.018 | antithrombin | complex with thrombin and heparin | 1TB6_I |
ID | I04.018 | antithrombin | Dimer of latent and active molecules | 2ANT |
ID | I04.018 | antithrombin | 2B4X_I | |
ID | I04.018 | antithrombin | complex between antithrombin, synthetic heparin mimetic sr123781 and two s195a thrombin molecules | 2B5T_I |
ID | I04.018 | antithrombin | Ser137Ala/Val317Cys/Thr401Cys variant | 2BEH_I |
ID | I04.018 | antithrombin | Ser195Ala variant; complex with factor Xa and pentasaccharide | 2GD4_I |
ID | I04.018 | antithrombin | P14 alanine variant | 2HIJ_I |
ID | I04.018 | antithrombin | domain-swapped dimer | 2ZNH_A |
ID | I04.018 | antithrombin | intermediate structure of antithrombin bound to the natural pentasaccharide | 3EVJ_I |
ID | I04.018 | antithrombin | hyperstable in-frame insertion variant of antithrombin | 4EB1_I |
ID | I04.019 | heparin cofactor II | 1JMJ | |
ID | I04.019 | heparin cofactor II | Ser195Ala variant; complex with thrombin | 1JMO_A |
ID | I04.020 | plasminogen activator inhibitor-1 | complex with reactive-centre loop pentapeptide | 1A7C |
ID | I04.020 | plasminogen activator inhibitor-1 | 1B3K | |
ID | I04.020 | plasminogen activator inhibitor-1 | 1C5G_A | |
ID | I04.020 | plasminogen activator inhibitor-1 | 1DB2 | |
ID | I04.020 | plasminogen activator inhibitor-1 | 1DVM | |
ID | I04.020 | plasminogen activator inhibitor-1 | latent form | 1DVN_A |
ID | I04.020 | plasminogen activator inhibitor-1 | 1LJ5_A | |
ID | I04.020 | plasminogen activator inhibitor-1 | plasminogen activator inhibitor-1 complex with somatomedin b domain of vitronectin | 1OC0_A |
ID | I04.020 | plasminogen activator inhibitor-1 | cleaved form | 3CVM |
ID | I04.020 | plasminogen activator inhibitor-1 | cleaved pai-1-stab | 3EOX_A |
ID | I04.020 | plasminogen activator inhibitor-1 | 3PB1_I | |
ID | I04.020 | plasminogen activator inhibitor-1 | 3Q02 | |
ID | I04.020 | plasminogen activator inhibitor-1 | 3Q03 | |
ID | I04.020 | plasminogen activator inhibitor-1 | 3R4L | |
ID | I04.020 | plasminogen activator inhibitor-1 | 3UT3 | |
ID | I04.020 | plasminogen activator inhibitor-1 | 4AQH | |
ID | I04.020 | plasminogen activator inhibitor-1 | 4G8O | |
ID | I04.020 | plasminogen activator inhibitor-1 | 4G8R | |
ID | I04.020 | plasminogen activator inhibitor-1 | 4IC0 | |
ID | I04.020 | plasminogen activator inhibitor-1 | 5BRR | |
ID | I04.020 | plasminogen activator inhibitor-1 | structure of tpa and pai-1 | 5ZLZ_I |
ID | I04.020 | plasminogen activator inhibitor-1 | discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1 | 6I8S_A |
ID | I04.020 | plasminogen activator inhibitor-1 | cleaved substrate variant | 9PAI |
ID | I04.020 | plasminogen activator inhibitor-1 | 3LW2 | |
ID | I04.020 | plasminogen activator inhibitor-1 | crystal structure of zebrafish plasminogen activator inhibitor-1 (pai-1) | 4DTE_A |
ID | I04.020 | plasminogen activator inhibitor-1 | crystal structure of latent rainbow trout plasminogen activator inhibitor 1 (pai-1) | 4KDS_A |
ID | I04.021 | protease nexin-1 | 4DY0 | |
ID | I04.021 | protease nexin-1 | 4DY7 | |
ID | I04.023 | plasmin inhibitor | 2R9Y_A | |
ID | I04.024 | C1 inhibitor | 1M6Q | |
ID | I04.024 | C1 inhibitor | latent form | 2OAY_A |
ID | I04.025 | neuroserpin | cleaved human neuroserpin | 3F02_A |
ID | I04.025 | neuroserpin | 3F5N_A | |
ID | I04.025 | neuroserpin | 3FGQ_A | |
ID | I04.025 | neuroserpin | Cleaved form | 1JJO |
ID | I04.028 | CrmA viral serpin | cleaved form | 1C8O_A |
ID | I04.028 | CrmA viral serpin | 1F0C_A | |
ID | I04.028 | CrmA viral serpin | cleaved form | 1M93_A |
ID | I04.030 | peptidase inhibitor 3 (rodent) | 1M37 | |
ID | I04.031 | alaserpin (Lepidoptera) | complex with rat trypsin II | 1K9O_I |
ID | I04.031 | alaserpin (Lepidoptera) | 1SEK | |
ID | I04.033 | myeloid and erythroid nuclear termination stage-specific protein (Gallus gallus) | M-loop deletion variant in the native conformation | 2DUT_A |
ID | I04.033 | myeloid and erythroid nuclear termination stage-specific protein (Gallus gallus) | cleaved conformation | 2H4P_A |
ID | I04.033 | myeloid and erythroid nuclear termination stage-specific protein (Gallus gallus) | M-loop deletion variant in the cleaved conformation | 2H4Q_A |
ID | I04.033 | myeloid and erythroid nuclear termination stage-specific protein (Gallus gallus) | native conformation | 2H4R_A |
ID | I04.035 | colligin 1 | molecular basis for the action of the collagen-specific chaperone hsp47 serpinh1 and its structure-specific client recognition. | 3ZHA_A |
ID | I04.035 | colligin 1 | crystal structure of a hsp47-collagen complex | 4AU2_A |
ID | I04.035 | colligin 1 | crystal structure of a hsp47-collagen complex | 4AU3_A |
ID | I04.035 | colligin 1 | crystal structure of hsp47 | 4AU4_A |
ID | I04.037 | thermopin (Thermobifida fusca) | 1MTP_A | |
ID | I04.037 | thermopin (Thermobifida fusca) | structure of reaction loop cleaved lamprey angiotensinogen | 5INW_A |
ID | I04.037 | thermopin (Thermobifida fusca) | structure of reaction loop cleaved lamprey angiotensinogen | 5INW_C |
ID | I04.043 | serpin 4 (Drosophila melanogaster) | cleaved serpin 42da (c 2 2 21) | 4P0F_A |
ID | I04.043 | serpin 4 (Drosophila melanogaster) | cleaved serpin 42da | 4P0O_A |
ID | I04.046 | myxoma virus serpin serp-1 | structure of the clinically used myxomaviral serine protease inhibitor1 (serp-1) ***caveat 6bj5 nag c 402 has wrong chirality at atom c1 | 6BJ5_B |
ID | I04.070 | SRPN2 (Anopheles gambiae) | 3PZF | |
ID | I04.070 | SRPN2 (Anopheles gambiae) | 4RO9_A | |
ID | I04.070 | SRPN2 (Anopheles gambiae) | 4ROA_A | |
ID | I04.070 | SRPN2 (Anopheles gambiae) | 4ROB_A | |
ID | I04.070 | SRPN2 (Anopheles gambiae) | 4RSQ_A | |
ID | I04.073 | miropin (Tannerella forsythia) | 5NCS_A | |
ID | I04.073 | miropin (Tannerella forsythia) | 5NCT_A | |
ID | I04.073 | miropin (Tannerella forsythia) | 5NCU_A | |
ID | I04.073 | miropin (Tannerella forsythia) | Val367Lys/Lys368Ala mutant | 5NCW_A |
ID | I04.078 | serpina3n (Mus musculus) | serpina3n, a murine orthologue of human antichymotrypsin | 1YXA_A |
ID | I04.086 | TmSPN48 (Tenebrio molitor) | 3OZQ_A | |
ID | I04.087 | AtSerpin1 (Arabidopsis thaliana) | 3LE2 | |
ID | I04.088 | serpin IRS-2 (Ixodes sp.) | 3NDA | |
ID | I04.091 | serpinA12 | 4IF8 | |
ID | I04.091 | serpinA12 | 4Y3K | |
ID | I04.091 | serpinA12 | 4Y40 | |
ID | I04.091 | serpinA12 | 5EI0 | |
ID | I04.953 | angiotensinogen | 1N9U | |
ID | I04.953 | angiotensinogen | 1N9V | |
ID | I04.953 | angiotensinogen | 2JP8 | |
ID | I04.953 | angiotensinogen | 2WXW | |
ID | I04.953 | angiotensinogen | complex with human renin | 2X0B_B |
ID | I04.953 | angiotensinogen | 3CK0 | |
ID | I04.953 | angiotensinogen | 3WOO | |
ID | I04.953 | angiotensinogen | 3WOR | |
ID | I04.953 | angiotensinogen | 4AA1 | |
ID | I04.953 | angiotensinogen | 4APH_P | |
ID | I04.953 | angiotensinogen | 4FYS_C | |
ID | I04.953 | angiotensinogen | complex with dipeptidyl-peptidase 3 | 5E2Q_B |
ID | I04.953 | angiotensinogen | crystal structure of human angiotensin i-deleted angiotensinogen | 5M3X_A |
ID | I04.953 | angiotensinogen | glycosylated form | 5M3Y_A |
ID | I04.953 | angiotensinogen | complex with renin | 6I3F_A |
ID | I04.953 | angiotensinogen | reactive center loop (rcl) cleaved form | 6I3I_A |
ID | I04.953 | angiotensinogen | 2WXX | |
ID | I04.953 | angiotensinogen | 2WXY | |
ID | I04.953 | angiotensinogen | 2WY0 | |
ID | I04.953 | angiotensinogen | 1SMR | |
ID | I04.953 | angiotensinogen | 2WXZ | |
ID | I04.953 | angiotensinogen | 2WY1 | |
ID | I04.953 | angiotensinogen | 2AH3 | |
ID | I04.953 | angiotensinogen | 3ER5_I | |
ID | I04.954 | corticosteroid-binding globulin | reactive loop cleaved form | 2VDX_A |
ID | I04.954 | corticosteroid-binding globulin | reactive loop cleaved form; complex with cortisol | 2VDY_A |
ID | I04.954 | corticosteroid-binding globulin | 4BB2 | |
ID | I04.954 | corticosteroid-binding globulin | 4C41 | |
ID | I04.954 | corticosteroid-binding globulin | 4C49 | |
ID | I04.954 | corticosteroid-binding globulin | struture of corticosteroid-binding globulin in complex with cortisol | 2V95_A |
ID | I04.955 | thyroxin-binding globulin | complex with thyroxine | 2CEO_A |
ID | I04.955 | thyroxin-binding globulin | reactive loop cleaved form | 2RIV_A |
ID | I04.955 | thyroxin-binding globulin | the reactive loop cleaved human thyroxine binding globulin complexed with thyroxine | 2RIW_A |
ID | I04.955 | thyroxin-binding globulin | 2XN3 | |
ID | I04.955 | thyroxin-binding globulin | 2XN5 | |
ID | I04.955 | thyroxin-binding globulin | 2XN6 | |
ID | I04.955 | thyroxin-binding globulin | 2XN7 | |
ID | I04.955 | thyroxin-binding globulin | 4X30 | |
ID | I04.955 | thyroxin-binding globulin | structural mechanism of hormone release in thyroxine binding globulin | 4YIA_A |
ID | I04.958 | ovalbumin | Arg339Thr mutant; cleaved form | 1JTI |
ID | I04.958 | ovalbumin | Uncleaved form | 1OVA_A |
ID | I04.958 | ovalbumin | 1P1Z | |
ID | I04.958 | ovalbumin | 1P4L | |
ID | I04.958 | ovalbumin | 1UHG_A | |
ID | I04.958 | ovalbumin | 1VAC | |
ID | I04.958 | ovalbumin | 3C8K | |
ID | I04.958 | ovalbumin | 3CVH | |
ID | I04.958 | ovalbumin | 3P9L | |
ID | I04.958 | ovalbumin | 3P9M | |
ID | I04.958 | ovalbumin | 3PAB | |
ID | I04.958 | ovalbumin | 4HKJ | |
ID | I04.979 | pigment epithelium derived factor | 1IMV_A | |
ID | I04.980 | maspin | 1WZ9_A | |
ID | I04.980 | maspin | 1XQG_A | |
ID | I04.980 | maspin | 1XQJ_A | |
ID | I04.980 | maspin | 1XU8_A | |
ID | I04.UPW | family I4 unassigned peptidase inhibitors | 3STO | |
ID | I04.UPW | family I4 unassigned peptidase inhibitors | native state | 2PEE_A |
ID | I04.UPW | family I4 unassigned peptidase inhibitors | latent state | 2PEF_A |
ID | I04.UPW | family I4 unassigned peptidase inhibitors | structure of a loop c-sheet serpin polymer | 2VH4_A |
ID | I04.UPW | family I4 unassigned peptidase inhibitors | 5C98_A | |
ID | I04.UPW | family I4 unassigned peptidase inhibitors | active form | 5DU3_A |
ID | I04.UPW | family I4 unassigned peptidase inhibitors | complex with dextran sulfate | 5DUQ_A |
IA | I05.001 | ascidian trypsin inhibitor | NMR structure | 1IW4 |
IJ | I06.001 | maize trypsin/factor XIIa inhibitor | 1BEA | |
IJ | I06.001 | maize trypsin/factor XIIa inhibitor | 1BFA | |
IJ | I06.002 | barley trypsin/factor XIIa inhibitor | structure of the barley limit dextrinase-limit dextrinase inhibitor complex | 4CVW_C |
IJ | I06.003 | ragi seed trypsin/alpha-amylase inhibitor | 1B1U | |
IJ | I06.003 | ragi seed trypsin/alpha-amylase inhibitor | NMR structure | 1BIP |
IJ | I06.003 | ragi seed trypsin/alpha-amylase inhibitor | 1JFO | |
IJ | I06.003 | ragi seed trypsin/alpha-amylase inhibitor | complex with Tenebrio molitor larval alpha-amylase | 1TMQ |
IJ | I06.UPW | family I6 unassigned peptidase inhibitors | 0.19 alpha-amylase inhibitor from wheat | 1HSS_A |
IE | I07.001 | trypsin inhibitor MCTI-1 (Momordica charantia) | 1EWU | |
IE | I07.003 | trypsin inhibitor EETI-II (Ecballium elaterium) | complex with porcine trypsin | 1H9H_I |
IE | I07.003 | trypsin inhibitor EETI-II (Ecballium elaterium) | mutant; complex with porcine trypsin | 1H9I_I |
IE | I07.003 | trypsin inhibitor EETI-II (Ecballium elaterium) | 1W7Z_A | |
IE | I07.003 | trypsin inhibitor EETI-II (Ecballium elaterium) | inhibitor cystine knot protein mcoeeti fused to the catalytically inactive barnase mutant h102a | 2C4B_A |
IE | I07.003 | trypsin inhibitor EETI-II (Ecballium elaterium) | NMR structure | 2ETI |
IE | I07.003 | trypsin inhibitor EETI-II (Ecballium elaterium) | 2IT7 | |
IE | I07.003 | trypsin inhibitor EETI-II (Ecballium elaterium) | NMR structure; Ile5Leu mutant | 2LET |
IE | I07.004 | macrocyclic squash trypsin inhibitor (Momordica cochinchinensis) | NMR structure | 1HA9 |
IE | I07.004 | macrocyclic squash trypsin inhibitor (Momordica cochinchinensis) | NMR structure | 1IB9 |
IE | I07.004 | macrocyclic squash trypsin inhibitor (Momordica cochinchinensis) | inhibitor cystine knot protein mcoeeti fused to the catalytically inactive barnase mutant h102a | 2C4B_A |
IE | I07.004 | macrocyclic squash trypsin inhibitor (Momordica cochinchinensis) | 2IT8 | |
IE | I07.004 | macrocyclic squash trypsin inhibitor (Momordica cochinchinensis) | 2MT8 | |
IE | I07.004 | macrocyclic squash trypsin inhibitor (Momordica cochinchinensis) | 2PO8 | |
IE | I07.004 | macrocyclic squash trypsin inhibitor (Momordica cochinchinensis) | 4GUX_D | |
IE | I07.004 | macrocyclic squash trypsin inhibitor (Momordica cochinchinensis) | 2LJS | |
IE | I07.005 | trypsin inhibitor CMTI-I (Cucurbita maxima) | NMR structure of Met8Leu mutant | 1BXJ |
IE | I07.005 | trypsin inhibitor CMTI-I (Cucurbita maxima) | NMR structure | 1CTI |
IE | I07.005 | trypsin inhibitor CMTI-I (Cucurbita maxima) | 1LU0 | |
IE | I07.005 | trypsin inhibitor CMTI-I (Cucurbita maxima) | complex with cattle anionic trypsin | 1PPE_I |
IE | I07.005 | trypsin inhibitor CMTI-I (Cucurbita maxima) | NMR structure | 2CTI |
IE | I07.005 | trypsin inhibitor CMTI-I (Cucurbita maxima) | 2STA_I | |
IE | I07.005 | trypsin inhibitor CMTI-I (Cucurbita maxima) | 2V1V | |
IE | I07.005 | trypsin inhibitor CMTI-I (Cucurbita maxima) | NMR structure | 3CTI |
IE | I07.006 | trypsin inhibitor CPTI (Cucurbita pepo) | 2BTC_I | |
IE | I07.006 | trypsin inhibitor CPTI (Cucurbita pepo) | 2STB_I | |
IE | I07.008 | trypsin inhibitor MCTI-II (Momordica charantia) | complex with cattle trypsin | 1F2S_I |
IE | I07.008 | trypsin inhibitor MCTI-II (Momordica charantia) | complex with pig trypsin | 1MCT_I |
IE | I07.018 | trypsin inhibitor MCTI-A (Momordica charantia) | 1MCT | |
IA | I08.001 | chymotrypsin/elastase inhibitor (Ascaris-type) | complex with pig pancreatic elastase | 1EAI_C |
IA | I08.003 | Bombina trypsin inhibitor | NMR structure | 1HX2 |
IA | I08.006 | inducible metallopeptidase inhibitor (Galleria mellonella) | 3SSB | |
IA | I08.006 | inducible metallopeptidase inhibitor (Galleria mellonella) | complex with thermolysin | 3SSB_C |
IA | I08.007 | Ascaris trypsin inhibitor | NMR structure; pH 4.75 | 1ATA |
IA | I08.007 | Ascaris trypsin inhibitor | NMR structure; pH 2.4 | 1ATB |
IA | I08.007 | Ascaris trypsin inhibitor | NMR structure; pH 4.75 | 1ATD |
IA | I08.007 | Ascaris trypsin inhibitor | NMR structure | 1ATE |
IA | I08.008 | cathepsin G/chymotrypsin inhibitor (Apis mellifera) | NMR structure | 1CCV |
IA | I08.010 | Ancylostoma caninum anticoagulant peptide c2 | NMR structure | 1COU |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1AO3 | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1ATZ | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1AUQ | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1FE8 | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1FNS | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1IJB | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1IJK | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1M10 | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1OAK | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1SQ0 | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1U0N | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 1UEX | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 2ADF | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 2MHP | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 2MHQ | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 3GXB | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 3HXO | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 3HXQ | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 3PPV | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 3PPW | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 3PPX | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 3PPY | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 3ZQK | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 4C29 | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 4C2A | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 4C2B | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 4DMU | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 4NT5 | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | 5BV8 | |
IA | I08.954 | von Willebrand factor inhibitor unit 2 | crystal structure of monomeric von willebrand factor d`d3 assembly | 6N29_A |
IA | I08.UPW | family I8 unassigned peptidase inhibitors | 1U0O | |
JC | I09.001 | subtilisin propeptide | complex with subtilisin I168 Ser221Cys mutant | 1SCJ_B |
JC | I09.001 | subtilisin propeptide | complex with mutant subtilisin BPN | 1SPB_P |
JC | I09.001 | subtilisin propeptide | azide complex of engineered subtilisin | 3BGO_P |
JC | I09.001 | subtilisin propeptide | prosubtilisin substrate complex of subtilisin subt_bacam | 3CNQ_P |
JC | I09.001 | subtilisin propeptide | substrate complex of fluoride-sensitive engineered subtilisin subt_bacam | 3CO0_P |
JC | I09.001 | subtilisin propeptide | anion-triggered engineered subtilisin subt_bacam | 3F49_S |
JC | I09.002 | peptidase A inhibitor 1 (Pleurotus ostreatus) | complex with subtilisin BPN' | 1V5I_B |
I- | I10.001 | marinostatin | 1IXU | |
IN | I11.001 | ecotin | complex with brachyurin | 1AZZ_C |
IN | I11.001 | ecotin | 1ECY | |
IN | I11.001 | ecotin | 1ECZ | |
IN | I11.001 | ecotin | 1EZS_A | |
IN | I11.001 | ecotin | 1EZU_A | |
IN | I11.001 | ecotin | 1FI8_C | |
IN | I11.001 | ecotin | complex with bovine thrombin | 1ID5_I |
IN | I11.001 | ecotin | 1IFG | |
IN | I11.001 | ecotin | complex with bovine chymotrypsin A | 1N8O_E |
IN | I11.001 | ecotin | Met84Arg mutant; complex with coagulation factor Xa | 1P0S_E |
IN | I11.001 | ecotin | Ala86His mutant; complex with rat anionic trypsin I, Asn143His mutant | 1SLU_A |
IN | I11.001 | ecotin | Ala86His mutant; complex with rat anionic trypsin I, Asn143His | 1SLV_A |
IN | I11.001 | ecotin | Ala86His mutant; complex with rat anionic trypsin I, Asn143His | 1SLW_A |
IN | I11.001 | ecotin | Ala86His mutant; complex with rat anionic trypsin I, Asn143His | 1SLX_A |
IN | I11.001 | ecotin | Mer84Arg mutant; complex with coagulation factor XIa catalytic domain | 1XX9_C |
IN | I11.001 | ecotin | mutant; complex with coagulation factor XIa catalytic domain | 1XXD_C |
IN | I11.001 | ecotin | mutant; complex with coagulation factor XIa catalytic domain | 1XXF_C |
IN | I11.001 | ecotin | 4IW4_C | |
IN | I11.001 | ecotin | 4NIY_E | |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | complex with cattle cationic trypsin | 1SMF_I |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | complex with cattle cationic trypsin | 1TAB_I |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | NMR structure | 1BBI |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | 1K9B | |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | NMR structure | 2BBI |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | 2OT6 | |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | 1H34 | |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | 2H20 | |
IF | I12.001 | Bowman-Birk inhibitor (Glycine-type) unit 1 | 1H34_A | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | NMR structure | 1JBL |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 1JBN | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 1O8Y | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 1O8Z | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | complex with cattle cationic trypsin | 1SFI_I |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 1T9E | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 2AB9 | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 3P8F_I | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 4ABI_B | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 4ABJ_B | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 4HGC_I | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 4K1E_B | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 4K8Y_B | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 4KEL_B | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | 4XOJ_B | |
IF | I12.002 | sunflower cyclic trypsin inhibitor | highly potent and selective plasmin inhibitors based on the sunflower trypsin inhibitor-1 scaffold attenuate fibrinolysis in plasma ***caveat 6d3x entry contains improper peptide linkages. | 6D3X_C |
IF | I12.002 | sunflower cyclic trypsin inhibitor | highly potent and selective plasmin inhibitors based on the sunflower trypsin inhibitor-1 scaffold attenuate fibrinolysis in plasma ***caveat 6d3y entry contains improper peptide linkages. | 6D3Y_C |
IF | I12.002 | sunflower cyclic trypsin inhibitor | protease sfti complex | 6D3Z_C |
IF | I12.002 | sunflower cyclic trypsin inhibitor | highly potent and selective plasmin inhibitors based on the sunflower trypsin inhibitor-1 scaffold attenuate fibrinolysis in plasma ***caveat 6d40 entry contains improper peptide linkages. | 6D40_C |
IF | I12.003 | Bowman-Birk trypsin inhibitor (Medicago-type) unit 1 | NMR structure | 1MVZ |
IF | I12.003 | Bowman-Birk trypsin inhibitor (Medicago-type) unit 1 | complex with bovine trypsin | 2ILN_I |
IF | I12.007 | rice Bowman-Birk inhibitor inhibitor unit 1 | crystal structure and functional study of the bowman-birk inhibitor from rice bran in complex with bovine trypsin | 2QN5_B |
IF | I12.008 | Bowman-Birk inhibitor (Glycine-type) unit 2 | 1G9I_I | |
IF | I12.008 | Bowman-Birk inhibitor (Glycine-type) unit 2 | 1SBW_I | |
IF | I12.008 | Bowman-Birk inhibitor (Glycine-type) unit 2 | complex with mung-bean bowman-birk inhibitor | 2QID_C |
IF | I12.008 | Bowman-Birk inhibitor (Glycine-type) unit 2 | 3MYW | |
IF | I12.008 | Bowman-Birk inhibitor (Glycine-type) unit 2 | 1PI2 | |
IF | I12.009 | Bowman-Birk inhibitor (Poaceae) inhibitor unit 1 | 1C2A_A1 | |
IF | I12.010 | Bowman-Birk inhibitor (Poaceae) inhibitor unit 2 | 1C2A_A2 | |
IF | I12.018 | lupin Bowman-Birk trypsin inhibitor | 1PBI | |
IF | I12.018 | lupin Bowman-Birk trypsin inhibitor | 1PBI_A | |
IF | I12.950 | Bowman-Birk inhibitor (Poaceae) inhibitor unit 4 | 1C2A_A4 | |
IF | I12.950 | Bowman-Birk inhibitor (Poaceae) inhibitor unit 4 | complex with trypsin | 1TX6_I |
IF | I12.950 | Bowman-Birk inhibitor (Poaceae) inhibitor unit 4 | high resolution structure of barley bowman-birk inhibitor | 2FJ8_A |
IF | I12.951 | Bowman-Birk inhibitor (Poaceae) inhibitor unit 3 | 1C2A_A3 | |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | 2AIH | |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | NMR structure | 1BBI_A |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | 1D6R_I | |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | 1K9B_A | |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | 2BBI_A | |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | complex with alpha-chymotrypsin from bovine pancreas | 5J4Q_B |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | complex with alpha-chymotrypsin from bovine pancreas | 5J4S_B |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | 1GM2 | |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | complex with beta-trypsin | 2G81_I |
IF | I12.UPW | family I12 unassigned peptidase inhibitors | 3RU4_B | |
IG | I13.001 | eglin c | complex with chymotrypsin A | 1ACB_I |
IG | I13.001 | eglin c | complex with subtilisin Carlsberg | 1CSE_I |
IG | I13.001 | eglin c | NMR structure | 1EGL |
IG | I13.001 | eglin c | cleaved at reactive centre | 1EGP |
IG | I13.001 | eglin c | complex with subtilisin | 1MEE_I |
IG | I13.001 | eglin c | complex with subtilisin BPN' | 1SBN_I |
IG | I13.001 | eglin c | complex with subtilisin BPN' | 1SIB_I |
IG | I13.001 | eglin c | complex with thermitase | 1TEC_I |
IG | I13.001 | eglin c | N-acetyl eglin C; complex with subtilisin Carlsberg | 2SEC_I |
IG | I13.001 | eglin c | complex with thermitase | 2TEC_I |
IG | I13.001 | eglin c | complex with thermitase | 3TEC_I |
IG | I13.001 | eglin c | 4B1T_B | |
IG | I13.001 | eglin c | 4B2A_B | |
IG | I13.001 | eglin c | 4B2B_B | |
IG | I13.001 | eglin c | 4B2C_B | |
IG | I13.001 | eglin c | complex with chymotrypsin C | 4H4F_B |
IG | I13.003 | chymotrypsin inhibitor 2 | complex of fragments 1-40 and 41-64 | 1CIQ |
IG | I13.003 | chymotrypsin inhibitor 2 | NMR structure; complex of fragments 1-40 and 41-64 | 1CIR |
IG | I13.003 | chymotrypsin inhibitor 2 | 1CIS_A | |
IG | I13.003 | chymotrypsin inhibitor 2 | Ile76Val mutant | 1COA |
IG | I13.003 | chymotrypsin inhibitor 2 | Met59 replaced by tetraglutamine mutant | 1CQ4 |
IG | I13.003 | chymotrypsin inhibitor 2 | complex with subtilisin BPN' | 1LW6_I |
IG | I13.003 | chymotrypsin inhibitor 2 | complex with subtilisin BPN' | 1TM1_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Met59Lys mutant; complex with subtilisin BPN' | 1TM3_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Met59Gly mutant; complex with subtilisin BPN' | 1TM4_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Met59Ala mutant; complex with subtilisin BPN' | 1TM5 _I |
IG | I13.003 | chymotrypsin inhibitor 2 | Met59Tyr mutant; complex with subtilisin BPN' | 1TM7_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Met59Phe mutant; complex with subtilisin BPN' | 1TMG_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Tyr61Ala mutant; complex with subtilisin BPN' | 1TO1_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Met59Lys mutant; complex with subtilisin BPN' at pH 9 | 1TO2_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Thr58Ala mutant; complex with subtilisin BPN' | 1Y1K_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Thr58Pro mutant; complex with subtilisin BPN' | 1Y33_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Glu60Ala mutant; complex with subtilisin BPN' | 1Y34_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Glu60Ser mutant; complex with subtilisin BPN' | 1Y3B_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Arg62Ala mutant; complex with subtilisin BPN' | 1Y3C_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Arg67Ala mutant; complex with subtilisin BPN' | 1Y3D_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Phe69Ala mutant; complex with subtilisin BPN' | 1Y3F_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Arg65Ala mutant; complex with subtilisin BPN' | 1Y48_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Met59Arg, Glu60Ser mutant; complex with subtilisin BPN' | 1Y4A_I |
IG | I13.003 | chymotrypsin inhibitor 2 | Ser31Ala, Glu33Ala and Glu34Ala mutant | 1YPA |
IG | I13.003 | chymotrypsin inhibitor 2 | Ser31Gly, Glu33Ala and Glu34Ala mutant | 1YPB |
IG | I13.003 | chymotrypsin inhibitor 2 | Glu33Ala and Glu34Ala mutant | 1YPC |
IG | I13.003 | chymotrypsin inhibitor 2 | 2CI2 | |
IG | I13.003 | chymotrypsin inhibitor 2 | complex with subtilisin BPN' | 2SNI_I |
IG | I13.003 | chymotrypsin inhibitor 2 | NMR structure | 3CI2 |
IG | I13.003 | chymotrypsin inhibitor 2 | structure of subtilase subhal from bacillus halmapalus - complex with chymotrypsin inhibitor ci2a | 5FBZ_A |
IG | I13.003 | chymotrypsin inhibitor 2 | complex of subtilase subty from bacillus sp. ty145 with chymotrypsin inhibitor ci2a | 5FFN_A |
IG | I13.004 | glutamyl peptidase II inhibitor (bitter gourd) | 1VBW_A | |
IG | I13.008 | inhibitor of trypsin and Hageman factor (Cucurbita maxima) | NMR structure or cleaved form | 1HYM |
IG | I13.008 | inhibitor of trypsin and Hageman factor (Cucurbita maxima) | NMR structure | 1MIT |
IG | I13.008 | inhibitor of trypsin and Hageman factor (Cucurbita maxima) | NMR structure | 1TIN |
IG | I13.011 | buckwheat peptidase inhibitor I | crystal structure of buckwheat trypsin inhibitor rbti at 1.84 angstromresolution | 3RDY_A |
IG | I13.UPW | family I13 unassigned peptidase inhibitors | 1DWM | |
IM | I14.001 | hirudin | complex with human thrombin | 1AD8_I |
IM | I14.001 | hirudin | complex with human thrombin | 1AE8_I |
IM | I14.001 | hirudin | complex with human thrombin | 1AFE_I |
IM | I14.001 | hirudin | complex with human thrombin | 1AHT_I |
IM | I14.001 | hirudin | complex with human thrombin | 1AWF_I |
IM | I14.001 | hirudin | complex with human thrombin | 1AY6_I |
IM | I14.001 | hirudin | complex with human thrombin | 1BA8_C |
IM | I14.001 | hirudin | complex with human thrombin | 1BB0_C |
IM | I14.001 | hirudin | complex with human thrombin and proflavin | 1BCU_I |
IM | I14.001 | hirudin | 1CA8 | |
IM | I14.001 | hirudin | 1D3D | |
IM | I14.001 | hirudin | 1D3P | |
IM | I14.001 | hirudin | 1D3Q | |
IM | I14.001 | hirudin | 1D3T | |
IM | I14.001 | hirudin | 1D4P | |
IM | I14.001 | hirudin | complex with human thrombin and N-[(benzyloxy)carbonyl]-beta-phenyl-D-phenylalanyl- N-(1S,3E)-1-[dihydroxy(diphenoxy)-lambda~5~- phosphanyl]-4-methoxybut-3-en-1-yl-L-prolinamide | 1H8D_I |
IM | I14.001 | hirudin | complex with human thrombin and N-[(benzyloxy)carbonyl]-beta-phenyl-D-phenylalanyl- N-[(1S)-4-methoxy-1-phosphonobutyl]-L-prolinamide | 1H8I_I |
IM | I14.001 | hirudin | complex with prethrombin | 1HAG_I |
IM | I14.001 | hirudin | complex with alpha-thrombin | 1HAH_I |
IM | I14.001 | hirudin | NMR structure of residues 1-51 | 1HIC |
IM | I14.001 | hirudin | 1HRT_I | |
IM | I14.001 | hirudin | 1HXE_I | |
IM | I14.001 | hirudin | 1HXF_I | |
IM | I14.001 | hirudin | 1NO9 | |
IM | I14.001 | hirudin | 1QHR | |
IM | I14.001 | hirudin | 1QJ1 | |
IM | I14.001 | hirudin | 1QJ6 | |
IM | I14.001 | hirudin | 1QJ7 | |
IM | I14.001 | hirudin | 1TMT | |
IM | I14.001 | hirudin | 1TMU | |
IM | I14.001 | hirudin | 1UMA | |
IM | I14.001 | hirudin | 1WBG | |
IM | I14.001 | hirudin | NMR structure | 2HIR |
IM | I14.001 | hirudin | 2JOO | |
IM | I14.001 | hirudin | sulfo-hirudin; complex with thrombin | 2PW8_I |
IM | I14.001 | hirudin | 2UUF | |
IM | I14.001 | hirudin | 2UUJ | |
IM | I14.001 | hirudin | 2UUK | |
IM | I14.001 | hirudin | 2V3O | |
IM | I14.001 | hirudin | 2ZC9 | |
IM | I14.001 | hirudin | 2ZDA | |
IM | I14.001 | hirudin | 2ZDV | |
IM | I14.001 | hirudin | 2ZF0 | |
IM | I14.001 | hirudin | 2ZFF | |
IM | I14.001 | hirudin | 2ZFP | |
IM | I14.001 | hirudin | 2ZGB | |
IM | I14.001 | hirudin | 2ZGX | |
IM | I14.001 | hirudin | 2ZHQ | |
IM | I14.001 | hirudin | 2ZI2 | |
IM | I14.001 | hirudin | 2ZIQ | |
IM | I14.001 | hirudin | 2ZNK | |
IM | I14.001 | hirudin | 2ZO3 | |
IM | I14.001 | hirudin | 3D49 | |
IM | I14.001 | hirudin | 3DHK | |
IM | I14.001 | hirudin | 3DT0 | |
IM | I14.001 | hirudin | 3DUX | |
IM | I14.001 | hirudin | 3EGK | |
IM | I14.001 | hirudin | 3EQ0 | |
IM | I14.001 | hirudin | 3LDX | |
IM | I14.001 | hirudin | 3UTU | |
IM | I14.001 | hirudin | 4AX9 | |
IM | I14.001 | hirudin | 4BAH | |
IM | I14.001 | hirudin | 4BAK | |
IM | I14.001 | hirudin | 4BAM | |
IM | I14.001 | hirudin | 4BAN | |
IM | I14.001 | hirudin | 4BAQ | |
IM | I14.001 | hirudin | NMR structure; Lys47Glu mutant | 4HIR |
IM | I14.001 | hirudin | 4LXB | |
IM | I14.001 | hirudin | 4MLF | |
IM | I14.001 | hirudin | 4YES | |
IM | I14.001 | hirudin | NMR structure; Lys47Glu mutant | 5HIR |
IM | I14.001 | hirudin | NMR structure; Lys47Glu mutant | 6HIR |
IM | I14.001 | hirudin | 1IHT | |
IM | I14.001 | hirudin | complex with prothrombin | 1A2C_I |
IM | I14.001 | hirudin | complex with thrombin | 1A46_I |
IM | I14.001 | hirudin | complex with thrombin | 1A4W_I |
IM | I14.001 | hirudin | complex with thrombin | 1A5G_I |
IM | I14.001 | hirudin | complex with thrombin | 1A61_I |
IM | I14.001 | hirudin | complex with human thrombin | 1B5G_I |
IM | I14.001 | hirudin | 1DOJ_B | |
IM | I14.001 | hirudin | 1K21 | |
IM | I14.001 | hirudin | 1K22 | |
IM | I14.001 | hirudin | 1NRS_I | |
IM | I14.001 | hirudin | 1TMB_I | |
IM | I14.001 | hirudin | 1TMU_J | |
IM | I14.001 | hirudin | 1VZQ | |
IM | I14.001 | hirudin | 1W7G | |
IM | I14.001 | hirudin | 1WAY | |
IM | I14.001 | hirudin | human thrombin complex with fragment-based small molecules occupying the s1 pocket | 2BVR_I |
IM | I14.001 | hirudin | human thrombin complex with fragment-based small molecules occupying the s1 pocket | 2BVS_I |
IM | I14.001 | hirudin | design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker | 2BVX_I |
IM | I14.001 | hirudin | design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker | 2BXT_I |
IM | I14.001 | hirudin | design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker | 2BXU_I |
IM | I14.001 | hirudin | 2C8W | |
IM | I14.001 | hirudin | 2C8X | |
IM | I14.001 | hirudin | 2C8Y | |
IM | I14.001 | hirudin | 2C8Z | |
IM | I14.001 | hirudin | 2C90 | |
IM | I14.001 | hirudin | 2C93 | |
IM | I14.001 | hirudin | 2R2M | |
IM | I14.001 | hirudin | 2ZFQ | |
IM | I14.001 | hirudin | 2ZFR | |
IM | I14.001 | hirudin | 2ZG0 | |
IM | I14.001 | hirudin | 2ZHE | |
IM | I14.001 | hirudin | 2ZHF | |
IM | I14.001 | hirudin | 2ZHW | |
IM | I14.001 | hirudin | 3BIU | |
IM | I14.001 | hirudin | HUMAN THROMBIN-IN COMPLEX WITH UB-THR11 | 3BIV |
IM | I14.001 | hirudin | 3F68 | |
IM | I14.001 | hirudin | 3HAT_I | |
IM | I14.001 | hirudin | complex with alpha-thrombin | 3HTC_I |
IM | I14.001 | hirudin | 3P17 | |
IM | I14.001 | hirudin | 3QTO | |
IM | I14.001 | hirudin | 3QTV | |
IM | I14.001 | hirudin | 3QWC | |
IM | I14.001 | hirudin | 3QX5 | |
IM | I14.001 | hirudin | 3RLW | |
IM | I14.001 | hirudin | 3RLY | |
IM | I14.001 | hirudin | 3RM0 | |
IM | I14.001 | hirudin | 3RM2 | |
IM | I14.001 | hirudin | 3RML | |
IM | I14.001 | hirudin | 3RMM | |
IM | I14.001 | hirudin | 3RMN | |
IM | I14.001 | hirudin | 3RMO | |
IM | I14.001 | hirudin | 3SHA | |
IM | I14.001 | hirudin | 3SHC | |
IM | I14.001 | hirudin | 3SI3 | |
IM | I14.001 | hirudin | 3SI4 | |
IM | I14.001 | hirudin | 3SV2 | |
IM | I14.001 | hirudin | 3T5F | |
IM | I14.001 | hirudin | 3TU7 | |
IM | I14.001 | hirudin | 3U98 | |
IM | I14.001 | hirudin | 3U9A | |
IM | I14.001 | hirudin | 3UWJ | |
IM | I14.001 | hirudin | 4BAO | |
IM | I14.001 | hirudin | 4E7R | |
IM | I14.001 | hirudin | complex with human thrombin | 4HTC_I |
IM | I14.001 | hirudin | 4LOY | |
IM | I14.001 | hirudin | 4N3L | |
IM | I14.001 | hirudin | 4NZE | |
IM | I14.001 | hirudin | 4UD9 | |
IM | I14.001 | hirudin | 4UDW | |
IM | I14.001 | hirudin | 4UE7 | |
IM | I14.001 | hirudin | 4UEH | |
IM | I14.001 | hirudin | thrombin in complex with 4-(((1-((2s)-1-((2r)-2-( benzylsulfonylamino)-3-phenyl-propanoyl)pyrrolidin-2-yl)-1- oxo-ethyl)amino)methyl)benzamidine | 4UFD_I |
IM | I14.001 | hirudin | thrombin in complex with (2r)-2-(benzylsulfonylamino)-n-(2-( (4-carbamimidoylphenyl)methylamino)-2-oxo-butyl)-3-phenyl- propanamide | 4UFE_I |
IM | I14.001 | hirudin | thrombin in complex with (2r)-2-(benzylsulfonylamino)-n-(2-( (4-carbamimidoylphenyl)methylamino)-2-oxo-ethyl)-n-methyl- 3-phenyl-propanamide | 4UFF_I |
IM | I14.001 | hirudin | thrombin in complex with (2r)-2-(benzylsulfonylamino)-n-(( 1s)-2-((4-carbamimidoylphenyl)methylamino)-1-methyl-2-oxo- ethyl)-n-methyl-3-phenyl-propanamide ethane | 4UFG_I |
IM | I14.001 | hirudin | thrombin inhibitor | 5A2M_I |
IM | I14.001 | hirudin | 5AF9 | |
IM | I14.001 | hirudin | thrombin in complex with (s)-n-(2-(aminomethyl)-5-chlorobenzyl)-1- ((benzylsulfonyl)-d-arginyl)pyrrolidine-2-carboxamide | 5JFD_I |
IM | I14.001 | hirudin | thrombin in complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide | 5JZY_I |
IM | I14.001 | hirudin | thrombin in complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (5-chloro-2-(hydroxymethyl)benzy l)pyrrolidine-2-carboxamide | 5LCE_I |
IM | I14.001 | hirudin | thrombin in complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (2-(aminomethyl)-5-chlorobenzyl) pyrrolidine-2-carboxamide | 5LPD_I |
IM | I14.001 | hirudin | thrombin mutant a190s in complex with (s) -1 - ((r) -2-amino-3,3- diphenylpropanoyl) -n- (3-chlorobenzyl) pyrrolidine-2-carboxamide | 5MJT_D |
IM | I14.001 | hirudin | thrombin mutant a190s in complex with (s)-1-(d-phenylalanyl)-n-(3- chlorobenzyl)pyrrolidine-2-carboxamide | 5MLS_D |
IM | I14.001 | hirudin | thrombin mutant a190s in complex with (s)-1-(d-phenylalanyl)-n-(4- carbamimidoylbenzyl)pyrrolidine-2-carboxamide | 5MM6_I |
IM | I14.001 | hirudin | complex with thrombin | 6EO8_I |
IM | I14.001 | hirudin | complex with thrombin | 6EO9_I |
IM | I14.001 | hirudin | thrombin in complex with mi2100 ((s)-n-(2-(aminomethyl)-5- chlorobenzyl)-1-((benzylsulfonyl)-l-arginyl)pyrrolidine-2- carboxamide) | 6GBW_I |
IM | I14.001 | hirudin | complex with human thrombin and methoxypropylboronic acid derivative | 1AI8_I |
IM | I14.001 | hirudin | complex with thrombin | 1A3B_I |
IM | I14.001 | hirudin | complex with thrombin | 1A3E_I |
IM | I14.001 | hirudin | complex with human thrombin | 1ABI_I |
IM | I14.001 | hirudin | 1C1U_I | |
IM | I14.001 | hirudin | 1C1V_I | |
IM | I14.001 | hirudin | 1C1W_I | |
IM | I14.001 | hirudin | 1C4U | |
IM | I14.001 | hirudin | 1C5L | |
IM | I14.001 | hirudin | 1C5N | |
IM | I14.001 | hirudin | 1C5O | |
IM | I14.001 | hirudin | 1D9I | |
IM | I14.001 | hirudin | 1FPC_I | |
IM | I14.001 | hirudin | 1GHV | |
IM | I14.001 | hirudin | 1GHW | |
IM | I14.001 | hirudin | 1GHX | |
IM | I14.001 | hirudin | 1GHY | |
IM | I14.001 | hirudin | 1GJ4 | |
IM | I14.001 | hirudin | 1GJ5 | |
IM | I14.001 | hirudin | 1IHS_I | |
IM | I14.001 | hirudin | 1NM6 | |
IM | I14.001 | hirudin | 1NT1 | |
IM | I14.001 | hirudin | 1NY2 | |
IM | I14.001 | hirudin | 1O2G | |
IM | I14.001 | hirudin | 1QBV_E | |
IM | I14.001 | hirudin | complex with thrombin | 1RIW_D |
IM | I14.001 | hirudin | 1SB1 | |
IM | I14.001 | hirudin | 1SL3 | |
IM | I14.001 | hirudin | 1TA2 | |
IM | I14.001 | hirudin | 1TA6 | |
IM | I14.001 | hirudin | 1TMT_J | |
IM | I14.001 | hirudin | 1TWX | |
IM | I14.001 | hirudin | 1VR1_I | |
IM | I14.001 | hirudin | 1XM1 | |
IM | I14.001 | hirudin | 1YPE | |
IM | I14.001 | hirudin | 1YPG | |
IM | I14.001 | hirudin | 1YPJ | |
IM | I14.001 | hirudin | 1YPK | |
IM | I14.001 | hirudin | 1YPL | |
IM | I14.001 | hirudin | 1YPM | |
IM | I14.001 | hirudin | 1ZRB | |
IM | I14.001 | hirudin | 2GDE | |
IM | I14.001 | hirudin | 2HGT_J | |
IM | I14.001 | hirudin | 2PKS | |
IM | I14.001 | hirudin | 3VXE | |
IM | I14.001 | hirudin | 3VXF | |
IM | I14.001 | hirudin | complex with human thrombin | 1AIX_I |
IM | I14.001 | hirudin | complex with human thrombin and BMS-186282 synthetic inhibitor | 1BMM_I |
IM | I14.001 | hirudin | complex with human thrombin and BMS-186282 synthetic inhibitor | 1BMN_I |
IM | I14.001 | hirudin | 1DWB_I | |
IM | I14.001 | hirudin | 1DWC_I | |
IM | I14.001 | hirudin | 1DWD_I | |
IM | I14.001 | hirudin | 1DWE | |
IM | I14.001 | hirudin | 2CF8 | |
IM | I14.001 | hirudin | 2CF9 | |
IM | I14.001 | hirudin | 4AYV | |
IM | I14.001 | hirudin | 4AYY | |
IM | I14.001 | hirudin | 4AZ2 | |
IM | I14.001 | hirudin | 1THR_I | |
IM | I14.002 | haemadin | Human alpha-Thrombin-Haemadin Complex | 1E0F |
IM | I15.001 | hirustasin | 1BX7 | |
IM | I15.001 | hirustasin | hirustasin from hirudo medicinalis at 1.4 angstroms | 1BX8_A |
IM | I15.001 | hirustasin | complex with pig tissue kallikrein | 1HIA_I |
IM | I15.005 | guamerin (Hirudo nipponia) | the crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor | 3BG4_D |
IM | I15.007 | antistasin inhibitor unit 1 | 1SKZ | |
IM | I15.008 | antistasin inhibitor unit 2 | 1SKZ_A | |
IM | I15.012 | gigastasin (Haementaria sp.) | complex with complement component C1s | 5UBM_I |
IM | I15.UPW | family I15 unassigned peptidase inhibitors | complex with cationic trypsin | 6MRQ |
IY | I16.003 | streptomyces subtilisin inhibitor | complex with subtilisin BPN' | 2SIC_I |
IY | I16.003 | streptomyces subtilisin inhibitor | modified; complex with cattle cationic trypsin | 2TLD_I |
IY | I16.003 | streptomyces subtilisin inhibitor | Met73Lys mutant; complex with subtilisin Bpn' | 3SIC_I |
IY | I16.003 | streptomyces subtilisin inhibitor | 3SSI | |
IY | I16.003 | streptomyces subtilisin inhibitor | complex with subtilisin BPN' | 5SIC_I |
IY | I16.017 | ScNPI inhibitor (Streptomyces caespitosus) | crystal structure of streptomyces caespitosus sermetstatin | 4HWX_A |
IY | I16.017 | ScNPI inhibitor (Streptomyces caespitosus) | complex with Bacillus licheniformis subtilisin | 4HX2_B |
IY | I16.017 | ScNPI inhibitor (Streptomyces caespitosus) | complex with snapalysin | 4HX3_B |
IP | I17.001 | secretory leukocyte peptidase inhibitor domain 2 | 2Z7F | |
IP | I17.001 | secretory leukocyte peptidase inhibitor domain 2 | 4DOQ | |
IP | I17.001 | secretory leukocyte peptidase inhibitor domain 2 | theoretical model | 1CJH |
IP | I17.002 | elafin | complex with pig pancreatic elastase | 1FLE_I |
IP | I17.002 | elafin | NMR structure | 2REL |
IP | I17.002 | elafin | exploring cystine dense peptide space to open a unique molecular toolbox | 6ATU_A |
IP | I17.004 | chelonianin inhibitor unit 2 | 1ZLG | |
IP | I17.004 | chelonianin inhibitor unit 2 | 1UDK | |
IP | I17.950 | secretory leukocyte peptidase inhibitor domain 1 | complex with neutrophil elastase | 2Z7F_I |
IP | I17.950 | secretory leukocyte peptidase inhibitor domain 1 | 1TWP | |
JD | I18.001 | mustard trypsin inhibitor-2 | NMR structure | 1JXC |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | complex with cattle chymotrypsin A | 1GL0_I |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | NMR structure | 1WO9 |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | complex with trypsin (Fusarium oxysporum ) | 2VU8_I |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | 1KGM_A | |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | 1KIO_A | |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | 1KJ0_A | |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | complex with crayfish trypsin | 2F91_B |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | 2XTT_A | |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | 3TVJ | |
IW | I19.001 | peptidase inhibitor LMPI (Orthoptera) inhibitor unit 1 | 4DJZ_H | |
IW | I19.011 | peptidase inhibitor LGPI (Orthoptera) inhibitor unit 2 | complex with cattle chymotrypsin A | 1GL1_I |
IW | I19.011 | peptidase inhibitor LGPI (Orthoptera) inhibitor unit 2 | NMR structure | 1PMC |
IW | I19.011 | peptidase inhibitor LGPI (Orthoptera) inhibitor unit 2 | NMR structure | 1KGM |
IW | I19.011 | peptidase inhibitor LGPI (Orthoptera) inhibitor unit 2 | NMR structure | 1KIO |
JO | I20.001 | potato peptidase inhibitor II inhibitor unit 1 | complex with streptogrisin B | 4SGB_I |
JO | I20.003 | tomato peptidase inhibitor II inhibitor unit 1 | complex with subtilisin Carlsberg | 1OYV_I |
JO | I20.003 | tomato peptidase inhibitor II inhibitor unit 1 | 1PJU_A | |
JO | I20.950 | potato peptidase inhibitor II inhibitor unit 2 | 4SGB | |
JO | I20.952 | tobacco peptidase inhibitor II inhibitor unit 3 | NMR structure | 2JZM |
JO | I20.952 | tobacco peptidase inhibitor II inhibitor unit 3 | NMR structure; single repeat domain only | 1CE3 |
JO | I20.952 | tobacco peptidase inhibitor II inhibitor unit 3 | NMR structure; C2 domain | 1QH2_A |
JO | I20.953 | tomato peptidase inhibitor II inhibitor unit 2 | 1PJU | |
JO | I20.UNW | family I20 unassigned peptidase inhibitor homologues | NMR structure | 1YTP |
JO | I20.UNW | family I20 unassigned peptidase inhibitor homologues | NMR structure | 2JYY |
JO | I20.UPW | family I20 unassigned peptidase inhibitors | NMR structure; C1-T1 domains | 1FYB_A |
JO | I20.UPW | family I20 unassigned peptidase inhibitors | NMR structure; T1 domain | 1TIH |
JO | I20.UPW | family I20 unassigned peptidase inhibitors | NMR structure; C2 domain | 1QH2_B |
I- | I22.001 | BsuPI peptidase inhibitor (Bacillus subtilis) | 3ISY | |
IH | I25.001 | cystatin A | NMR structure | 1CYU |
IH | I25.001 | cystatin A | NMR structure | 1CYV |
IH | I25.001 | cystatin A | NMR structure | 1DVC |
IH | I25.001 | cystatin A | NMR structure | 1DVD |
IH | I25.001 | cystatin A | NMR structure | 1GD3 |
IH | I25.001 | cystatin A | NMR structure; Pro25Ser mutant | 1GD4 |
IH | I25.001 | cystatin A | NMR structure; dimer | 1N9J |
IH | I25.001 | cystatin A | complex with cathepsin H | 1NB3_I |
IH | I25.001 | cystatin A | complex with cathepsin H | 1NB5_I |
IH | I25.001 | cystatin A | 3K9M_C | |
IH | I25.001 | cystatin A | 3KFQ | |
IH | I25.001 | cystatin A | 3KSE | |
IH | I25.003 | cystatin B | complex with papain | 1STF_I |
IH | I25.003 | cystatin B | stefin b (cystatin b) tetramer | 2OCT_A |
IH | I25.003 | cystatin B | 4N6V | |
IH | I25.004 | cystatin C | Dimer with domain swapping | 1G96_A |
IH | I25.004 | cystatin C | n-truncated human cystatin c; dimeric form with 3d domain swapping | 1R4C_A |
IH | I25.004 | cystatin C | 3d domain-swapped human cystatin c with amyloid-like intermolecular beta-sheets | 1TIJ_A |
IH | I25.004 | cystatin C | 3GAX | |
IH | I25.004 | cystatin C | 3NX0 | |
IH | I25.004 | cystatin C | 3PS8 | |
IH | I25.004 | cystatin C | 3QRD | |
IH | I25.004 | cystatin C | 3S67 | |
IH | I25.004 | cystatin C | 3SVA | |
IH | I25.005 | cystatin D | 1RN7 | |
IH | I25.005 | cystatin D | 1ROA | |
IH | I25.006 | cystatin 6 | 4N6L | |
IH | I25.006 | cystatin 6 | 4N6M | |
IH | I25.006 | cystatin 6 | complex with oxidised human legumain | 4N6N_B |
IH | I25.006 | cystatin 6 | complex with human legumain | 4N6O_B |
IH | I25.006 | cystatin 6 | dimer | 6FK0_A |
IH | I25.007 | cystatin F | dimer | 2CH9 |
IH | I25.011 | ovocystatin | NMR structure | 1A67 |
IH | I25.011 | ovocystatin | NMR structure | 1A90 |
IH | I25.011 | ovocystatin | 1CEW_I | |
IH | I25.011 | ovocystatin | complex with falcipain-2 | 1YVB_I |
IH | I25.014 | phytocystatin | 4TX4 | |
IH | I25.014 | phytocystatin | complex with papain | 3IMA_B |
IH | I25.014 | phytocystatin | 6VLP | |
IH | I25.014 | phytocystatin | 6VLQ_1 | |
IH | I25.017 | kininogen inhibitor unit 3 | 1NY2 | |
IH | I25.017 | kininogen inhibitor unit 3 | 2WOK | |
IH | I25.017 | kininogen inhibitor unit 3 | 4ASQ_P | |
IH | I25.017 | kininogen inhibitor unit 3 | 4ASR_P | |
IH | I25.017 | kininogen inhibitor unit 3 | 4ECB | |
IH | I25.017 | kininogen inhibitor unit 3 | 4ECC | |
IH | I25.034 | potato multicystatin inhibitor unit 2 | 2W9P_A | |
IH | I25.040 | potato multicystatin inhibitor unit 8 | 2W9Q | |
IH | I25.040 | potato multicystatin inhibitor unit 8 | 4LZI | |
IH | I25.049 | sialostatin L (Ixodes scapularis) | 3L0R | |
IH | I25.049 | sialostatin L (Ixodes scapularis) | 3LI7 | |
IH | I25.049 | sialostatin L (Ixodes scapularis) | crystal structure of sialostatin l | 4ZM8_A |
IH | I25.049 | sialostatin L (Ixodes scapularis) | 3LH4 | |
IH | I25.049 | sialostatin L (Ixodes scapularis) | selenomethionine derivative | 3MWZ |
IH | I25.051 | cystatin Hv-CPI1 (Hordeum vulgare) | saccharum officinarum canecystatin-1 in space group c2221 | 3UL5_A |
IH | I25.051 | cystatin Hv-CPI1 (Hordeum vulgare) | saccharum officinarum canecystatin-1 in space group p6422 | 3UL6_A |
IH | I25.052 | cystatin Hv-CPI-2 (Hordeum vulgare) | NMR structure | 1EQK_A |
IH | I25.067 | fetuin-B domain 2 | crystal structure of mouse fetuin-b | 6HPV_A |
IH | I25.067 | fetuin-B domain 2 | complex with crayfish astacin | 6HT9_B |
IH | I25.UPA | subfamily I25A unassigned peptidase inhibitors | 5ZC1_A | |
IH | I25.UPB | subfamily I25B unassigned peptidase inhibitors | crystal structure of al-cpi | 4IT7_A |
II | I27.001 | calpastatin inhibitor unit 1 | 1NX0 | |
II | I27.001 | calpastatin inhibitor unit 1 | 1NX1 | |
II | I27.001 | calpastatin inhibitor unit 1 | complex with calpain 2 | 3DF0_C |
II | I27.UPW | family I27 unassigned peptidase inhibitors | complex with calpain 2 | 3BOW_C |
II | I27.UPW | family I27 unassigned peptidase inhibitors | 11-residue peptide; complex with pig calpain small subunit domain 6 | 1NX0_C |
II | I27.UPW | family I27 unassigned peptidase inhibitors | 11-residue peptide; complex with pig calpain small subunit domain 6 | 1NX1_C |
JF | I29.003 | cathepsin H propeptide | theoretical model; Asp158Glu mutant in complex with E64c | 1EUX |
JF | I29.003 | cathepsin H propeptide | propapain | 1PCI_A |
JF | I29.007 | cathepsin K propeptide | a mutant rabbit cathepsin k with a nitrile inhibitor | 2F7D_A |
JF | I29.UPW | family I29 unassigned peptidase inhibitors | 2GHU_A | |
JF | I29.UPW | family I29 unassigned peptidase inhibitors | complex with a cysteine protease | 2OUL_A |
JF | I29.UPW | family I29 unassigned peptidase inhibitors | structure of digestive procathepsin l 3 of tenebrio molitor larval midgut | 3QT4_A |
IX | I31.002 | MHC II invariant chain p41 form | complex with cathepsin L | 1ICF_I |
IX | I31.002 | MHC II invariant chain p41 form | NMR structure; ectoplasmic trimerization domain only | 1IIE |
IX | I31.002 | MHC II invariant chain p41 form | NMR structure; inhibitor domain only | 1L3H |
IX | I31.951 | insulin-like growth factor binding protein | c-terminal domain of insulin-like growth factor binding protein-1 isolated from human amniotic fluid | 1ZT3_A |
IX | I31.951 | insulin-like growth factor binding protein | c-terminal domain of insulin-like growth factor binding protein-1 isolated from human amniotic fluid complexed with iron(ii) | 1ZT5_A |
IX | I31.951 | insulin-like growth factor binding protein | structural basis for the inhibition of insulin-like growth factors by igf binding proteins | 2DSQ_G |
IX | I31.952 | insulin-like growth factor binding protein 3 | 1WQJ | |
IX | I31.952 | insulin-like growth factor binding protein 3 | 2DSP | |
IX | I31.952 | insulin-like growth factor binding protein 3 | structural basis for the inhibition of insulin-like growth factors by igf binding proteins | 2DSQ_B |
IX | I31.952 | insulin-like growth factor binding protein 3 | structural basis for the inhibition of insulin-like growth factors by igf binding proteins | 2DSR_G |
IX | I31.952 | insulin-like growth factor binding protein 3 | 1RMJ | |
IX | I31.952 | insulin-like growth factor binding protein 3 | 1BOE_A | |
IX | I31.952 | insulin-like growth factor binding protein 3 | 1H59 | |
IX | I31.953 | insulin-like growth factor binding protein 2 | 2H7T | |
IX | I31.UPW | family I31 unassigned peptidase inhibitors | 4MZV | |
IX | I31.UPW | family I31 unassigned peptidase inhibitors | crystal structure of epcam in complex with scfv | 6I07_A |
IX | I31.UPW | family I31 unassigned peptidase inhibitors | 2MAE | |
IX | I31.UPW | family I31 unassigned peptidase inhibitors | 2MVK | |
IX | I31.UPW | family I31 unassigned peptidase inhibitors | 2MVL | |
IV | I32.001 | BIRC-1 protein | flagellin derivative in complex with the nlr protein naip5 | 5YUD_A |
IV | I32.001 | BIRC-1 protein | BIR2 domain | 2VM5_A |
IV | I32.003 | BIRC-3 protein | NMR structure | 1QBH |
IV | I32.003 | BIRC-3 protein | BIR3 domain | 2UVL_A |
IV | I32.004 | XIAP caspase inhibitor | NMR structure | 1C9Q_A |
IV | I32.004 | XIAP caspase inhibitor | NMR structure | 1F9X |
IV | I32.004 | XIAP caspase inhibitor | NMR structure; complex with nonapeptide from SmaC/Diablo | 1G3F_A |
IV | I32.004 | XIAP caspase inhibitor | complex with SmaC | 1G73 |
IV | I32.004 | XIAP caspase inhibitor | complex with caspase 3 | 1I3O_E |
IV | I32.004 | XIAP caspase inhibitor | complex with caspase-7 | 1I51_E |
IV | I32.004 | XIAP caspase inhibitor | CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX | 1KMC |
IV | I32.004 | XIAP caspase inhibitor | complex with caspase-9 | 1NW9_A |
IV | I32.005 | survivin | dimer | 1E31 |
IV | I32.005 | survivin | 1F3H_A | |
IV | I32.005 | survivin | NMR structure | 1XOX |
IV | I32.005 | survivin | complex with borealin-incenp core | 2QFA_A |
IV | I32.005 | survivin | complex with borealin | 2RAW_A |
IV | I32.005 | survivin | complex with borealin (20-78) | 2RAX_A |
IV | I32.005 | survivin | crystal structure of human survivin bound to histone h3 phosphorylatedon threonine-3. | 3UEC_A |
IV | I32.005 | survivin | bound to histone h3 phosphorylatedon threonine-3 (c2 space group). | 3UED_A |
IV | I32.005 | survivin | crystal structure of human survivin k62a mutant bound to n-terminal histone h3 | 3UEE_A |
IV | I32.005 | survivin | crystal structure of human survivin bound to histone h3 (c2 space group). | 3UEF_A |
IV | I32.005 | survivin | crystal structure of human survivin k62a mutant | 3UEG_A |
IV | I32.005 | survivin | crystal structure of human survivin h80a mutant | 3UEH_A |
IV | I32.005 | survivin | crystal structure of human survivin e65a mutant | 3UEI_A |
IV | I32.005 | survivin | complex with t3 phosphorylated h3(1-15) peptide | 3UIG_A |
IV | I32.005 | survivin | complex with smac/diablo(1-15) peptide | 3UIH_A |
IV | I32.005 | survivin | complex with h3(1-10) peptide | 3UII_A |
IV | I32.005 | survivin | Lys62Tyr/His80Trp mutant; complex with smac/diablo(1-15) peptide | 3UIJ_A |
IV | I32.005 | survivin | Lys62Tyr/His80Trp mutant; complex with h3(1-10) peptide | 3UIK_A |
IV | I32.005 | survivin | crystal structure of survivin bound to the n-terminal tail of hsgo1 | 4A0I_A |
IV | I32.005 | survivin | crystal structure of survivin bound to the phosphorylated n- terminal tail of histone h3 | 4A0J_A |
IV | I32.005 | survivin | crystal structure of survivin bound to the phosphorylated n- terminal tail of histone h3 | 4A0N_A |
IV | I32.005 | survivin | 1M4M | |
IV | I32.006 | BIRC-6 protein | 3CEG | |
IV | I32.007 | BIRC-7 protein | 1OXN_A | |
IV | I32.007 | BIRC-7 protein | 1OXQ_A | |
IV | I32.007 | BIRC-7 protein | 1OY7_A | |
IV | I32.007 | BIRC-7 protein | ML-IAP/XIAP chimera; complex with a nonomer peptide derived from smac | 1TW6_A |
IV | I32.007 | BIRC-7 protein | ML-IAP/XIAP chimera; complex with a tetramer peptide (Ala-Val-Pro-Trp) | 2I3H_A |
IV | I32.007 | BIRC-7 protein | ML-IAP/XIAP chimera; complex with a peptidomimetic | 2I3I_A |
IV | I32.007 | BIRC-7 protein | ML-IAP/XIAP chimera; complex with a peptidomimetic | 3F7H_A |
IV | I32.007 | BIRC-7 protein | ML-IAP/XIAP chimera; complex with a peptidomimetic | 3F7I_A |
IV | I32.007 | BIRC-7 protein | 1QBH_A | |
IV | I32.007 | BIRC-7 protein | 2L9M | |
IV | I32.007 | BIRC-7 protein | CIAP1-BIR3 domain; complex with N-terminal peptide from caspase-9 | 3D9T_A |
IV | I32.007 | BIRC-7 protein | CIAP1-BIR3 domain; complex with N-terminal peptide from smac/diablo (avpiaq). | 3D9U_A |
IV | I32.007 | BIRC-7 protein | 3M1D | |
IV | I32.007 | BIRC-7 protein | 3MUP | |
IV | I32.007 | BIRC-7 protein | 3OZ1 | |
IV | I32.007 | BIRC-7 protein | 3T6P | |
IV | I32.007 | BIRC-7 protein | 3UW4_A | |
IV | I32.007 | BIRC-7 protein | 4EB9 | |
IV | I32.007 | BIRC-7 protein | 4HY4 | |
IV | I32.007 | BIRC-7 protein | 4HY5 | |
IV | I32.007 | BIRC-7 protein | 4KMN | |
IV | I32.007 | BIRC-7 protein | 4LGE | |
IV | I32.007 | BIRC-7 protein | 4LGU | |
IV | I32.007 | BIRC-7 protein | 4MTI | |
IV | I32.007 | BIRC-7 protein | 4MU7 | |
IV | I32.007 | BIRC-7 protein | small molecule inhibitors of iap | 5M6N_A |
IV | I32.007 | BIRC-7 protein | crystal structure of ciap1-bir3 in complex with a covalently bound sm | 6EXW_A |
IV | I32.007 | BIRC-7 protein | NMR structure | 1F9X_A |
IV | I32.007 | BIRC-7 protein | 1G73_C | |
IV | I32.007 | BIRC-7 protein | 1I4O_C | |
IV | I32.007 | BIRC-7 protein | complex with caspase-7 | 1KMC_C |
IV | I32.007 | BIRC-7 protein | 1TFQ | |
IV | I32.007 | BIRC-7 protein | 1TFT | |
IV | I32.007 | BIRC-7 protein | 2ECG | |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with a SMAC-mimetic compound | 2JK7_A |
IV | I32.007 | BIRC-7 protein | 2KNA | |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with a SMAC-mimetic compound | 2OPY_A |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with AVPF | 2OPZ_A |
IV | I32.007 | BIRC-7 protein | XIAP-BIR1 domain (i222 form) | 2POI_A |
IV | I32.007 | BIRC-7 protein | complex with TAB1 | 2POP_B |
IV | I32.007 | BIRC-7 protein | XIAP-BIR1 domain (p21 form) | 2QRA_D |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with a bivalent SMAC-mimetic compound | 2VSL_A |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with a SMAC-mimetic compound, smac005 | 3CLX_D |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with a SMAC-mimetic compound, smac010 ***caveat 3cm2 chirality errors at cb of thr j355 | 3CM2_D |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with SMAC-mimetic compound, SMAC005 | 3CM7_C |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with a SMAC-mimetic compound | 3EYL_A |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with a bivalent compound | 3G76_A |
IV | I32.007 | BIRC-7 protein | XIAP-BIR3 domain; complex with CS3 | 3HL5_A |
IV | I32.007 | BIRC-7 protein | 3UW5_A | |
IV | I32.007 | BIRC-7 protein | 4EC4 | |
IV | I32.007 | BIRC-7 protein | 4HY0 | |
IV | I32.007 | BIRC-7 protein | 4IC2 | |
IV | I32.007 | BIRC-7 protein | 4IC3 | |
IV | I32.007 | BIRC-7 protein | 4J3Y | |
IV | I32.007 | BIRC-7 protein | 4J44 | |
IV | I32.007 | BIRC-7 protein | 4J45 | |
IV | I32.007 | BIRC-7 protein | 4J46 | |
IV | I32.007 | BIRC-7 protein | 4J47 | |
IV | I32.007 | BIRC-7 protein | 4J48 | |
IV | I32.007 | BIRC-7 protein | 4KJU | |
IV | I32.007 | BIRC-7 protein | 4KJV | |
IV | I32.007 | BIRC-7 protein | 4KMP | |
IV | I32.007 | BIRC-7 protein | 4MTZ | |
IV | I32.007 | BIRC-7 protein | 4OXC | |
IV | I32.007 | BIRC-7 protein | 4WVS | |
IV | I32.007 | BIRC-7 protein | 4WVT | |
IV | I32.007 | BIRC-7 protein | 4WVU | |
IV | I32.007 | BIRC-7 protein | 5C0K | |
IV | I32.007 | BIRC-7 protein | 5C0L | |
IV | I32.007 | BIRC-7 protein | 5C3H | |
IV | I32.007 | BIRC-7 protein | 5C3K | |
IV | I32.007 | BIRC-7 protein | 5C7A | |
IV | I32.007 | BIRC-7 protein | 5C7B | |
IV | I32.007 | BIRC-7 protein | 5C7C | |
IV | I32.007 | BIRC-7 protein | 5C7D | |
IV | I32.007 | BIRC-7 protein | 5C83 | |
IV | I32.007 | BIRC-7 protein | 5C84 | |
IV | I32.007 | BIRC-7 protein | small molecule inhibitors of iap | 5M6E_A |
IV | I32.007 | BIRC-7 protein | small molecule inhibitors of iap | 5M6F_A |
IV | I32.007 | BIRC-7 protein | small molecule inhibitors of iap | 5M6H_A |
IV | I32.007 | BIRC-7 protein | small molecule inhibitors of iap | 5M6L_A |
IV | I32.007 | BIRC-7 protein | small molecule inhibitors of iap | 5M6M_A |
IV | I32.007 | BIRC-7 protein | xiap in complex with small molecule | 5OQW_A |
IV | I32.007 | BIRC-7 protein | crystal structure of xiap-bir3 in complex with a ciap1-selective sm | 6EY2_A |
IV | I32.007 | BIRC-7 protein | structure of xiap-bir1 domain in complex with an nf023 analog | 6GJW_A |
IV | I32.007 | BIRC-7 protein | fragment derived xiap inhibitor | 6H6Q_A |
IV | I32.007 | BIRC-7 protein | fragment derived xiap inhibitor | 6H6R_A |
IV | I32.007 | BIRC-7 protein | structure of xiap-bir1 v86e mutant | 6QCI_A |
IV | I32.007 | BIRC-7 protein | 3EB5 | |
IV | I32.007 | BIRC-7 protein | 3EB6 | |
IV | I32.007 | BIRC-7 protein | 3M0A | |
IV | I32.007 | BIRC-7 protein | 3M0D | |
IV | I32.008 | BIRC-8 protein | BIR domain | 1XB0_A |
IV | I32.008 | BIRC-8 protein | BIR domain | 1XB1_A |
IV | I32.009 | DIAP1 (Drosophila melanogaster) | 1JD4 | |
IV | I32.009 | DIAP1 (Drosophila melanogaster) | complex with GRIM nonapeptide | 1JD5 |
IV | I32.009 | DIAP1 (Drosophila melanogaster) | complex with HID nonapeptide | 1JD6 |
IV | I32.009 | DIAP1 (Drosophila melanogaster) | complex with DRONC | 1Q4Q_A |
IV | I32.009 | DIAP1 (Drosophila melanogaster) | DIAP1-BIR1 domain; complex with a reaper peptide | 1SDZ_A |
IV | I32.009 | DIAP1 (Drosophila melanogaster) | DIAP1-BIR1 domain; complex with a GRIM peptide | 1SE0_A |
IV | I32.009 | DIAP1 (Drosophila melanogaster) | 3SIP_E | |
IV | I32.009 | DIAP1 (Drosophila melanogaster) | 3SIQ | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 1OXN | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 1OXQ | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 1OY7 | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 1TW6 | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 2I3H | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 2I3I | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 3F7G | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 3F7H | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 3F7I | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 3GT9 | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 3GTA | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 3UW5_A | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | 4AUQ | |
IV | I32.UPW | family I32 unassigned peptidase inhibitors | cryo-em structure of the naip5-nlrc4-flagellin inflammasome | 6B5B_A |
IR | I33.001 | aspin | 1F32_A | |
IR | I33.001 | aspin | complex with pig pepsin | 1F34_B |
JA | I34.001 | saccharopepsin inhibitor | Met31Lys, Met32Lys mutant; complex with saccharopepsin | 1DP5_B |
JA | I34.001 | saccharopepsin inhibitor | complex with saccharopepsin | 1DPJ_B |
JA | I34.001 | saccharopepsin inhibitor | Met31Lys, Met32Lys mutant; complex with saccharopepsin | 1G0V_B |
IT | I35.001 | timp-1 | NMR structure; N-terminal domain | 1D2B |
IT | I35.001 | timp-1 | theoretical model | 1LQN |
IT | I35.001 | timp-1 | NMR structure; complex with human stromelysin catalytic domain | 1OO9_A |
IT | I35.001 | timp-1 | complex with human stromelysin catalytic domain | 1UEA_B |
IT | I35.001 | timp-1 | inhibitory domain; complex with MMP-1 catalytic domain | 2J0T_D |
IT | I35.001 | timp-1 | 3MA2_B | |
IT | I35.001 | timp-1 | 3V96_A | |
IT | I35.001 | timp-1 | Leu34Gly mutant; complex with matrix metalloproteinase-3 catalytic domain (mmp-3cd) | 6MAV_B |
IT | I35.001 | timp-1 | Leu34Gly/Leu133Pro/Leu151Cys/Gly154Ala mutant; complex with matrix metalloproteinase-3 catalytic domain (mmp-3cd) | 6N9D_B |
IT | I35.002 | timp-2 | complex with MT1-MMP | 1BQQ_T |
IT | I35.002 | timp-2 | 1BUV_T | |
IT | I35.002 | timp-2 | flexibility and variability of timp binding: x-ray structure of the complex between collagenase-3/mmp-13 and timp-2 | 2E2D_C |
IT | I35.002 | timp-2 | 1BR9 | |
IT | I35.002 | timp-2 | complex with progelatinase A | 1GXD_C |
IT | I35.002 | timp-2 | NMR structure; N-terminal domain | 2TMP |
IT | I35.002 | timp-2 | 4ILW_A | |
IT | I35.003 | timp-3 | complex with ADAM17 peptidase | 3CKI_B |
IU | I36.001 | Streptomyces metallopeptidase inhibitor | NMR structure | 1BHU |
IE | I37.001 | potato metallocarboxypeptidase inhibitor | NMR structure | 1H20 |
IE | I37.001 | potato metallocarboxypeptidase inhibitor | 4CPA_I | |
IE | I37.001 | potato metallocarboxypeptidase inhibitor | NMR structure | 6JIC |
IK | I38.001 | metallopeptidase inhibitor (Erwinia) | complex with serralysin | 1SMP_I |
IK | I38.002 | aprin | complex with aeruginolysin | 1JIW_I |
IK | I38.002 | aprin | NMR structure | 2RN4 |
IL | I39.001 | alpha-2-macroglobulin | NMR structure of receptor domain | 1BV8 |
IL | I39.001 | alpha-2-macroglobulin | MG2 domain only | 2P9R_A |
IL | I39.001 | alpha-2-macroglobulin | 4ACQ | |
IL | I39.001 | alpha-2-macroglobulin | receptor-binding domain only | 1EDY |
IL | I39.001 | alpha-2-macroglobulin | receptor-binding domain | 1AYO_A |
IL | I39.008 | ECAM protein (Escherichia coli) | activated by porcine elastase | 4RTD |
IL | I39.008 | ECAM protein (Escherichia coli) | 4ZIQ | |
IL | I39.008 | ECAM protein (Escherichia coli) | 4ZIU | |
IL | I39.008 | ECAM protein (Escherichia coli) | 4ZJG | |
IL | I39.008 | ECAM protein (Escherichia coli) | 4ZJH | |
IL | I39.008 | ECAM protein (Escherichia coli) | 5A42 | |
IL | I39.008 | ECAM protein (Escherichia coli) | 4U48 | |
IL | I39.008 | ECAM protein (Escherichia coli) | Tyr1175Gly mutant | 4U4J |
IL | I39.008 | ECAM protein (Escherichia coli) | complex with methylamine | 4U59 |
IL | I39.950 | complement component C3 | Fragment C3D | 1C3D |
IL | I39.950 | complement component C3 | cr2-c3d complex structure | 1GHQ_A |
IL | I39.950 | complement component C3 | 1W2S | |
IL | I39.950 | complement component C3 | human complement component c3 | 2A73_A |
IL | I39.950 | complement component C3 | human complement component c3c | 2A74_A |
IL | I39.950 | complement component C3 | complex with EFB-c | 2GOX_A |
IL | I39.950 | complement component C3 | structure of complement c3b: insights into complement activation and regulation | 2HR0_A |
IL | I39.950 | complement component C3 | human complement component c3b | 2I07_A |
IL | I39.950 | complement component C3 | crig bound to c3c | 2ICE_A |
IL | I39.950 | complement component C3 | crig bound to c3b | 2ICF_A |
IL | I39.950 | complement component C3 | complex with EHP | 2NOJ_A |
IL | I39.950 | complement component C3 | human c3c in complex with the inhibitor compstatin | 2QKI_A |
IL | I39.950 | complement component C3 | complement c3b in complex with factor h domains 1-4 | 2WII_A |
IL | I39.950 | complement component C3 | c3 convertase (c3bbb) stabilized by scin | 2WIN_A |
IL | I39.950 | complement component C3 | 2WY7 | |
IL | I39.950 | complement component C3 | 2WY8 | |
IL | I39.950 | complement component C3 | 2XQW | |
IL | I39.950 | complement component C3 | 2XWB_A | |
IL | I39.950 | complement component C3 | 2XWJ | |
IL | I39.950 | complement component C3 | crystal structure of efb-c (n138a) / c3d complex | 3D5R_A |
IL | I39.950 | complement component C3 | crystal structure of efb-c (r131a) / c3d complex | 3D5S_A |
IL | I39.950 | complement component C3 | c3b in complex with a c3b specific fab | 3G6J_A |
IL | I39.950 | complement component C3 | 3L3O | |
IL | I39.950 | complement component C3 | 3L5N | |
IL | I39.950 | complement component C3 | 3NMS | |
IL | I39.950 | complement component C3 | 3OED | |
IL | I39.950 | complement component C3 | 3OHX | |
IL | I39.950 | complement component C3 | 3OXU | |
IL | I39.950 | complement component C3 | 3RJ3 | |
IL | I39.950 | complement component C3 | 3T4A | |
IL | I39.950 | complement component C3 | 4HW5 | |
IL | I39.950 | complement component C3 | 4HWJ | |
IL | I39.950 | complement component C3 | 4I6O | |
IL | I39.950 | complement component C3 | 4M76 | |
IL | I39.950 | complement component C3 | 4ONT | |
IL | I39.950 | complement component C3 | complement factor h in complex with the gm1 glycan | 4ZH1_A |
IL | I39.950 | complement component C3 | crystal structure of human complement c3b at 2.8 angstrom resolution | 5FO7_A |
IL | I39.950 | complement component C3 | complex with mcp (ccp1-4) | 5FO8_A |
IL | I39.950 | complement component C3 | crystal structure of human complement c3b in complex with cr1 (ccp15-17) | 5FO9_A |
IL | I39.950 | complement component C3 | complex with daf (ccp2-4) | 5FOA_A |
IL | I39.950 | complement component C3 | complex with smallpox inhibitor of complement (spice) | 5FOB_A |
IL | I39.950 | complement component C3 | properdin in complex with alternative pathway c3 convertase | 5M6W_A |
IL | I39.950 | complement component C3 | the structure of the tripartite complex between ospe, the c-terminal domains of factor h and c3dg | 5NBQ_A |
IL | I39.950 | complement component C3 | the structure of complement complex | 5O32_A |
IL | I39.950 | complement component C3 | structure of complement proteins complex | 5O35_A |
IL | I39.950 | complement component C3 | complement component c3b in complex with a nanobody | 6EHG_A |
IL | I39.950 | complement component C3 | n-terminally truncated c3d,g fragment of the complement system | 1QQF_A |
IL | I39.950 | complement component C3 | N-terminally truncated C3DG fragment | 1QSJ |
IL | I39.950 | complement component C3 | crystal structure of cobra venom factor, a co-factor for c3- and c5 convertase cvfbb | 3FRP_A |
IL | I39.950 | complement component C3 | 3HRZ | |
IL | I39.950 | complement component C3 | 3HS0 | |
IL | I39.950 | complement component C3 | 3PRX_B | |
IL | I39.950 | complement component C3 | 3PVM_B | |
IL | I39.950 | complement component C3 | structure of complement c5 in complex with small molecule inhibitor and cvf | 6I2X_B |
IL | I39.950 | complement component C3 | complex with an intact thioester | 2B39_A |
IL | I39.951 | complement component C4 | complement component c4b | 4XAM_A |
IL | I39.952 | complement component C5 | NMR structure of semi-synthetic C5A fragment | 1CFA |
IL | I39.952 | complement component C5 | NMR structure of C5A fragment | 1KJS |
IL | I39.952 | complement component C5 | 1XWE | |
IL | I39.952 | complement component C5 | human complement component 5 | 3CU7_A |
IL | I39.952 | complement component C5 | 3HQA | |
IL | I39.952 | complement component C5 | 3HQB | |
IL | I39.952 | complement component C5 | 3KLS | |
IL | I39.952 | complement component C5 | 3KM9 | |
IL | I39.952 | complement component C5 | 3PRX_A | |
IL | I39.952 | complement component C5 | 3PVM_A | |
IL | I39.952 | complement component C5 | 4A5W | |
IL | I39.952 | complement component C5 | 4E0S | |
IL | I39.952 | complement component C5 | 4P39 | |
IL | I39.952 | complement component C5 | 4UU9 | |
IL | I39.952 | complement component C5 | c5a; complex with its binding repebody | 5B4P_A |
IL | I39.952 | complement component C5 | complex with sky59 | 5B71_A |
IL | I39.952 | complement component C5 | ternary complex of human complement c5 with ornithodoros moubata omci and dermacentor andersoni raci3. | 5HCC_B |
IL | I39.952 | complement component C5 | ternary complex of human complement c5 with ornithodoros moubata omci and rhipicephalus microplus raci2 | 5HCD_B |
IL | I39.952 | complement component C5 | ternary complex of human complement c5 with ornithodoros moubata omci and rhipicephalus appendiculatus raci1 | 5HCE_B |
IL | I39.952 | complement component C5 | complex with eculizumab | 5I5K_B |
IL | I39.952 | complement component C5 | closed conformation of the membrane attack complex | 6H04_A |
IL | I39.952 | complement component C5 | structure of complement c5 in complex with small molecule inhibitor and cvf | 6I2X_C |
IL | I39.952 | complement component C5 | 4P3A | |
IL | I39.952 | complement component C5 | 4P3B | |
IL | I39.952 | complement component C5 | 4WB2 | |
IL | I39.952 | complement component C5 | 4WB3 | |
IL | I39.952 | complement component C5 | 1C5A | |
IL | I39.UPW | family I39 unassigned peptidase inhibitors | 2PN5_A | |
IL | I39.UPW | family I39 unassigned peptidase inhibitors | crystal structure of tep1s | 4LNV_A |
IL | I39.UPW | family I39 unassigned peptidase inhibitors | complex with masp-2 | 4FXG_A |
IL | I39.UPW | family I39 unassigned peptidase inhibitors | 4FXK_A | |
IL | I39.UPW | family I39 unassigned peptidase inhibitors | complement component c4b | 4XAM_C |
IL | I39.UPW | family I39 unassigned peptidase inhibitors | structure of the complex of human complement c4 with masp-2 rebuilt using imdff | 5JPM_A |
IL | I39.UPW | family I39 unassigned peptidase inhibitors | structure of human complement c4 rebuilt using imdff | 5JPN_A |
IL | I39.UPW | family I39 unassigned peptidase inhibitors | crystal structure of complement c4b re-refined using imdff | 5JTW_A |
JL | I42.001 | chagasin | 2FO8 | |
JL | I42.001 | chagasin | 2H7W | |
JL | I42.001 | chagasin | 2NNR_A | |
JL | I42.001 | chagasin | complex with human cathepsin l | 2NQD_A |
JL | I42.001 | chagasin | complex with a cysteine protease | 2OUL_B |
JL | I42.001 | chagasin | chagasin-cathepsin b complex | 3CBJ_B |
JL | I42.001 | chagasin | chagasin-cathepsin b | 3CBK_B |
JL | I42.001 | chagasin | complex with chagasin | 3E1Z_B |
JL | I42.001 | chagasin | NMR structure | 2C34 |
JL | I42.001 | chagasin | complex with papain | 2CIO_B |
JL | I42.003 | amoebiasin-2 | 3M86 | |
JL | I42.003 | amoebiasin-2 | 3M88 | |
JM | I43.001 | oprin | 2FCB | |
JM | I43.001 | oprin | 3WJJ | |
JM | I43.951 | immunoglobulin alpha Fc receptor | 1OVZ_A | |
JM | I43.951 | immunoglobulin alpha Fc receptor | extracellular fragment of fc alpha receptor i (cd89) | 1UCT_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | paired immunoglobulin-like receptor b (pirb) or leukocyte immunoglobulin-like receptor subfamily b member 3 (lilrb3) full extracellular domain | 6GRQ_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | paired immunoglobulin-like receptor b (pirb) or leukocyte immunoglobulin-like receptor subfamily b member 3 (lilrb3) full extracellular domain | 6GRS_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | paired immunoglobulin-like receptor b (pirb) or leukocyte immunoglobulin-like receptor subfamily b member 3 (lilrb3) full extracellular domain | 6GRT_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | ligand binding domain | 1G0X |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | complex with HLA-A2 | 1P7Q_D |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | ligand binding domain | 1UFU_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1UGN_A | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1VDG_A | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | structure of ul18, a peptide-binding viral mhc mimic, bound to a host inhibitory receptor | 3D2U_D |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 5KNM_D | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | binding properties to hla class i molecules and the structure of the leukocyte ig-like receptor a3 (lilra3/ilt6/lir4/cd85e) | 3Q2C_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2OTP_A | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3P2T | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | complex with h128-3 antibody | 6K7O_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | kir3dl1 in complex with hla-b*5701 | 3VH8_G |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | kir3dl1 in complex with hla-b*57:01.i80t | 3WUW_G |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | kir3dl1*005 in complex with hla-b*57:01 | 5B38_G |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | kir3dl1*015 in complex with hla-b*57:01 | 5B39_G |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | kir3dl1 in complex with hla-b*57:01-tw10 | 5T6Z_C |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | kir3dl1 in complex with hla-b*57:01 presenting tsnlqeqigw | 5T70_G |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3KGR | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3RP1 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | complex with HLA-G | 2DYP_D |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2GW5_A | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4LLA | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | extracellular domain | 5CJ8_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | complex with a collagen-like peptide | 5CJB_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 5EIQ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 5EIV | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2D3V | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2GI7 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | crystal structure of the glycoprotein vi loop truncation mutant pavs- papykn | 5OU7_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | crystal structure of glycoprotein vi in complex with collagen-peptide (gpo)5 | 5OU8_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | crystal structure of glycoprotein vi in complex with collagen-peptide (gpo)3 | 5OU9_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3WYR | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1B6U_A | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1EFX | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1M4K | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2DL2 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2DLI | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4N8V | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2C5D | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4RA0 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2JJS | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2JJT | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2UV3 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2WNG | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4CMM | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1DJS | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1E0O | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1EV2 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1GJO | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1II4 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1IIL | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1NUN | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1OEC | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1WVZ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2FDB | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PSQ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PVF | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PVY | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PWL | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PY3 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PZ5 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PZP | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PZR | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2Q0B | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3B2T | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3CAF | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3CLY | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3CU1 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3DAR | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3EUU | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3OJ2 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3OJM | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3RI1 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4J23 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4J95 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4J96 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4J97 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4J98 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4J99 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4WV1 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4RWH | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2CKN | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3AY4 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3SGJ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3SGK | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3WN5 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 5BW7 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | cocrystal structure of fc gamma receptor iiia interacting with affimerf4, a specific binding protein which blocks igg binding to the receptor. | 5ML9_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | cocrystal structure of fc gamma receptor iiia interacting with affimerg3, a specific binding protein which blocks igg binding to the receptor. | 5MN2_A |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1FHO | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2ID5 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4OQT | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2DM2 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2DM3 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4OF8 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2PKD | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1QCT | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4QQ5 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4QQC | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4QQJ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4QQT | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4QRC | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4R6V | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4TYE | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4TYG | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4TYI | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4TYJ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4UXQ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4XCU | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2YZ1 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4N68 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4HWN | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1KJC | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 5A2F | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2CQV | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2K0F | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2YR3 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4GOS | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4PBV | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4PBW | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1IGA | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1OW0 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2QEJ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3CHN | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2DL9 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3ZYI | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1Q70 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2ED7 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2ED8 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2ED9 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2EDB | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2EDD | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2EDE | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3AU4 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4URT | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3AXA | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4Y89 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2AGJ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4FOM | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1NKO | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1O7S | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1O7V | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2DF3 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2G5R | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2HRL | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2DBJ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2P0C | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3BPR | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3BRB | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3TCP | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4M3Q | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4MH7 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4MHA | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3ALP | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3SKU | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3U82 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3U83 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4FMF | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4MYW | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1DGI_R | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1NN8_R | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3EPC_R | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3EPD_R | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3EPF | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3J8F | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3J9F | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3UDW | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3URO | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4FQP | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1EAJ | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1F5W | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1JEW | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1KAC | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1P69 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1P6A | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1RSF | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2J12 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2J1K | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2NPL | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2W9L | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 2WBW | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3J6L | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3J6M | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3J6N | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3J6O | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1G0X_A | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1P7Q | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1UGN | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 1VDG | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 3D2U | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4LL9 | |
JM | I43.UPW | family I43 unassigned peptidase inhibitors | 4NO0 | |
JJ | I44.001 | metallocarboxypeptidase A inhibitor (Ascaris suum) | complex with human carboxypeptidase A1 | 3FJU_B |
IS | I46.001 | leech metallocarboxypeptidase inhibitor | complex with human carboxypeptidase A2 | 1DTD_B |
IS | I46.001 | leech metallocarboxypeptidase inhibitor | NMR structure | 1DTV_A |
IS | I46.001 | leech metallocarboxypeptidase inhibitor | NMR structure | 1ZFI |
IS | I46.001 | leech metallocarboxypeptidase inhibitor | NMR structure | 1ZFL |
IS | I46.001 | leech metallocarboxypeptidase inhibitor | Cys19Ala, Cys43Ala mutant; complex with cattle carboxypeptidase A | 2ABZ_C |
IH | I47.001 | latexin | complex with carboxypeptidase A4 | 2BK7_B |
IH | I47.001 | latexin | complex with carboxypeptidase A4 | 2BO9_B |
IH | I47.001 | latexin | 1WNH | |
IC | I48.001 | clitocypin | 3H6S | |
IC | I48.001 | clitocypin | complex with cathepsin V | 3H6S_E |
IC | I48.001 | clitocypin | 3H6R | |
IQ | I50.001 | baculovirus P35 caspase inhibitor | engineered mutant form cleaved by caspase | 1I3P |
IQ | I50.001 | baculovirus P35 caspase inhibitor | engineered mutant form cleaved by caspase | 1I3S |
IQ | I50.001 | baculovirus P35 caspase inhibitor | 1I4E_A | |
IQ | I50.001 | baculovirus P35 caspase inhibitor | 1P35_A | |
IQ | I50.001 | baculovirus P35 caspase inhibitor | alternative p35-caspase-8 complex | 2FUN_A |
JE | I51.001 | serine carboxypeptidase Y inhibitor (Saccharomyces cerevisiae) | complex with carboxypeptidase Y | 1WPX_B |
JE | I51.002 | phosphatidylethanolamine-binding protein | structure of mouse wild-type rkip | 6ENS_A |
JE | I51.002 | phosphatidylethanolamine-binding protein | 2IQX | |
JE | I51.002 | phosphatidylethanolamine-binding protein | 2IQY | |
JE | I51.002 | phosphatidylethanolamine-binding protein | structure of the rat rkip variant delta143-146 | 6ENT_A |
JE | I51.002 | phosphatidylethanolamine-binding protein | 1BD9 | |
JE | I51.002 | phosphatidylethanolamine-binding protein | complex with cacodylate | 1BEH |
JE | I51.002 | phosphatidylethanolamine-binding protein | 2L7W | |
JE | I51.002 | phosphatidylethanolamine-binding protein | 2QYQ | |
JE | I51.002 | phosphatidylethanolamine-binding protein | 1KN3 | |
JE | I51.002 | phosphatidylethanolamine-binding protein | 1A44 | |
JE | I51.002 | phosphatidylethanolamine-binding protein | 1B7A | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 3AXY | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 3J6B | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 1WKP | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 3J7Y | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 3J9M | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | structure of a native assembly intermediate of the human mitochondrialribosome with unfolded interfacial rrna | 5OOL_6 |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | structure of a native assembly intermediate of the human mitochondrialribosome with unfolded interfacial rrna | 5OOM_6 |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 1WKO | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 1QOU | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | crystal structure of phosphatidylethanolamine-binding protein, pfl0955c, from plasmodium falciparum | 2R77_A |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 1FJJ | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 1VI3 | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 1FUX | |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | phosphatidylethanolamine-binding protein from plasmodium vivax | 2GZQ_A |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | 39s large subunit of mitochondrial ribosome | 4CE4_b |
JE | I51.UPW | family I51 unassigned peptidase inhibitors | structure of the large subunit of the mammalian mitoribosome, part 2 of 2 | 4V1A_a |
IB | I52.001 | tick anticoagulant peptide (Ornithodorus sp.) | complex with bovine pancreatic trypsin inhibitor | 1D0D_A |
IB | I52.001 | tick anticoagulant peptide (Ornithodorus sp.) | complex with cattle factor Xa | 1KIG_I |
IB | I52.001 | tick anticoagulant peptide (Ornithodorus sp.) | NMR structure | 1TAP |
IB | I52.001 | tick anticoagulant peptide (Ornithodorus sp.) | NMR structure | 1TCP |
I- | I53.001 | madanin 1 (Haemaphysalis longicornis) | complex with thrombin | 4BOH_HL |
I- | I53.001 | madanin 1 (Haemaphysalis longicornis) | complex with prothrombin | 5L6N_I |
IK | I57.001 | staphostatin B | 1NYC | |
IK | I57.001 | staphostatin B | complex with staphopain | 1PXV_C |
IK | I57.001 | staphostatin B | 1QWX_A | |
IK | I57.001 | staphostatin B | wild type staphopain-staphostatin complex | 1Y4H_C |
IK | I58.001 | staphostatin A | NMR structure | 1OH1 |
IZ | I59.001 | triabin | complex with thrombin fragment | 1AVG_I |
IZ | I59.UPW | family I59 unassigned peptidase inhibitors | crystal of a leukotriene-binding salivary lipocalin | 5H9K_A |
IZ | I59.UPW | family I59 unassigned peptidase inhibitors | crystal structure of ltbp1 in complex with cleaved leukotriene c4 | 5H9L_A |
IZ | I59.UPW | family I59 unassigned peptidase inhibitors | crystal structure of ltbp1 y114a mutant in complex with leukotriene c4 | 5H9N_A |
IZ | I59.UPW | family I59 unassigned peptidase inhibitors | crystal structure of the ltbp1 leukotriene d4 complex | 5HA0_A |
IZ | I59.UPW | family I59 unassigned peptidase inhibitors | crystal structure of ltbp1 ltc4 complex collected on an in-house source | 5HAE_A |
JB | I63.001 | pro-eosinophil major basic protein | mature protein | 1H8U_A |
JB | I63.001 | pro-eosinophil major basic protein | embp heparin complex | 2BRS_A |
JB | I63.001 | pro-eosinophil major basic protein | 4QXX | |
JB | I63.002 | bothrojaracin | 2KV3 | |
JB | I63.002 | bothrojaracin | pancreatitis-associated protein 1 from human | 1UV0_A |
JB | I63.002 | bothrojaracin | 2GO0 | |
JB | I63.002 | bothrojaracin | 4MTH | |
JB | I63.002 | bothrojaracin | 2IMV | |
JB | I63.002 | bothrojaracin | 2IMY | |
JB | I63.002 | bothrojaracin | 1LIT | |
JB | I63.002 | bothrojaracin | 1QDD | |
JB | I63.002 | bothrojaracin | 3WBP | |
JB | I63.002 | bothrojaracin | 3WBQ | |
JB | I63.002 | bothrojaracin | 3WBR | |
JB | I63.002 | bothrojaracin | 4ZES | |
JB | I63.002 | bothrojaracin | 4ZET | |
JB | I63.002 | bothrojaracin | 1UMR | |
JB | I63.002 | bothrojaracin | 1UOS | |
JB | I63.002 | bothrojaracin | 4IOP | |
JB | I63.UNW | family I63 unassigned peptidase inhibitor homologues | 5AO5 | |
JB | I63.UNW | family I63 unassigned peptidase inhibitor homologues | 5AO6 | |
JB | I63.UNW | family I63 unassigned peptidase inhibitor homologues | ligand binding region of uparap at ph 7.4 | 5E4K_A |
JB | I63.UNW | family I63 unassigned peptidase inhibitor homologues | structure of ligand binding region of uparap at ph 5.3 | 5E4L_A |
JB | I63.UNW | family I63 unassigned peptidase inhibitor homologues | ligand binding region of uparap at ph 7.4 without calcium | 5EW6_A |
JB | I63.UNW | family I63 unassigned peptidase inhibitor homologues | 1EGG | |
JB | I63.UNW | family I63 unassigned peptidase inhibitor homologues | 1EGI | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1TDQ | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1GL4 | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1H4U | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1NPE | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1DQG | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1DQO | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1FWU | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1FWV | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1NDX | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1QO3 | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 1YMP | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 2QC9 | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 2RQZ | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 2RR0 | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 2RR2 | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 3P3N | |
JB | I63.UPW | family I63 unassigned peptidase inhibitors | 3P3P | |
I- | I66.003 | cospin (Coprinopsis cinerea) | 3N0K | |
I- | I66.003 | cospin (Coprinopsis cinerea) | high resolution structure of proteinase inhibitor from coprinopsis cinerea | 3VWC_A |
IF | I67.001 | bromein | NMR structure | 1BI6_L |
IF | I67.001 | bromein | NMR structure | 2BI6_L |
IF | I67.001 | bromein | NMR structure | 1BI6 |
IF | I67.001 | bromein | 2BI6 | |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | complex with bovine carboxypeptidase A | 1ZLH_B |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | 1ZLI | |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | NMR structure | 2JTO |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | NMR structure at pH 3.5 | 2K2X |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | NMR structure; intermediate IIIA | 2K2Y |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | 2K2Z | |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | 3D4U | |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | complex with carboxypeptidase B2 | 3D4U_B |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | 3LMS_B | |
JK | I68.001 | tick carboxypeptidase inhibitor (Rhipicephalus bursa) | 3OSL_B | |
I- | I69.002 | streptopain propeptide | precursor; Cys47Ser mutant | 1DKI_A |
I- | I71.001 | falstatin | complex with falcipain-2 | 3PNR_B |
JN | I73.001 | Veronica trypsin inhibitor | complex with trypsin | 2CMY_B |
JN | I73.001 | Veronica trypsin inhibitor | synthetic peptide; complex with trypsin | 2PLX_B |
JN | I73.002 | buckwheat trypsin inhibitor 2c | NMR structure | 2LQX |
I- | I74.001 | variegin (Amblyomma variegatum) | 3B23 | |
I- | I77.001 | anophelin | human alpha thrombin complex with anopheles gambiae ce5 anticoagulant | 5NHU_I |
I- | I77.001 | anophelin | complex with thrombin | 4E05 |
I- | I77.001 | anophelin | complex with human thrombin | 4E06 |
I- | I78.001 | Aspergillus elastase inhibitor | crystal form I | 3W0D |
I- | I78.001 | Aspergillus elastase inhibitor | crystal form II | 3W0E |
JH | I83.001 | AmFPI-1 (Antheraea sp.) | 3BT4 | |
IC | I85.001 | macrocypin 1 | 3H6Q | |
IA | I88.001 | oryctin (Oryctes rhinoceros) | NMR structure | 2KSW |
I- | I90.002 | trypsin inhibitor III (Spinacia oleracea) | Phe14Ala mutant; complex with cationic trypsin | 4AOQ_D |
I- | I90.002 | trypsin inhibitor III (Spinacia oleracea) | complex with cationic trypsin | 4AOR_A |
IV | I91.001 | F1L protein (vaccinia virus) | 2VTY | |
IV | I91.001 | F1L protein (vaccinia virus) | vaccinia virus f1l bound to bak bh3 | 4D2L_A |
IV | I91.001 | F1L protein (vaccinia virus) | vaccinia virus f1l bound to bim bh3 | 4D2M_A |
IV | I91.001 | F1L protein (vaccinia virus) | crystal structure of variola virus virulence factor f1l in complex with human bid bh3 domain | 5AJJ_A |
IV | I91.001 | F1L protein (vaccinia virus) | crystal structure of variola virus virulence factor f1l in complex with human bak bh3 domain | 5AJK_A |
I- | I92.001 | NvCI carboxypeptidase inhibitor (Nerita versicolor) | 4A94 | |
I- | I92.001 | NvCI carboxypeptidase inhibitor (Nerita versicolor) | complex with human carboxypeptidase A4 | 4A94_C |
I- | I92.001 | NvCI carboxypeptidase inhibitor (Nerita versicolor) | complex with human metallocarboxypeptidase O | 5MRV_C |
I- | I93.001 | Sizzled protein (Xenopus laevis) | structure of sizzled from xenopus laevis at 2.08 angstroms resolution | 5XGP_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of frizzled 7 crd | 5T44_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of frizzled 7 crd in complex with c24 fatty acid | 5URV_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of frizzled-7 crd with an inhibitor peptide fz7-21 | 5WBS_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | designed repeat protein in complex with fz7 | 6NE2_B |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | designed repeat protein specifically in complex with fz7crd | 6NE4_B |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of frizzled 7 crd in complex with f7.b fab | 6O3A_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of frizzled 7 crd in complex with f6 fab | 6O3B_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 5BPB | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 5BPQ | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 5BQC | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 5BQE | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 5CL1 | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 5CM4 | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | the crystal structure of fz4-crd in complex with palmitoleic acid | 5UWG_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | designed repeat protein in complex with fz4 | 6NE1_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | structural basis for recognition of frizzled proteins by clostridium difficile toxin b | 6C0B_B |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | cysteine-rich domain | 1IJX_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of frizzled 5 crd in complex with pam | 5URY_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of frizzled 5 crd in complex with bog | 5URZ_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of frizzled 5 crd in complex with f2.i fab | 6O39_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | cysteine-rich domain | 1IJY_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of xwnt8 in complex with the cysteine-rich domain offrizzled 8 | 4F0A_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | wnt signaling complex | 6AHY_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | frizzled-8 complex with designed surrogate wnt agonist, crystal form 1 | 5UN5_B |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | frizzled-8 complex with designed surrogate wnt agonist, a1 dataset | 5UN6_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | designed repeat protein in complex with fz8 | 6NDZ_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 1BNL | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 3HON | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | 3HSH | |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of the smoothened crd, native | 4C79_A |
I- | I93.UPW | family I93 unassigned peptidase inhibitors | crystal structure of the smoothened crd, selenomethionine- labeled | 4C7A_A |
I- | I94.001 | NleF protein (Escherichia coli) | complex with human caspase-9 | 3V3K_B |
I- | I96.002 | EapH1 protein | 1YN4 | |
I- | I96.002 | EapH1 protein | complex with human leukocyte elastase | 4NZL_B |
I- | I96.003 | EapH2 protein | 1YN5 | |
IF | I99.001 | Bowman-Birk-like trypsin inhibitor (Odorrana versabilis) | complex with bovine trypsin | 4U2W_B |